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The opportunistic fungal pathogen Candida albicans colonizes mucosal surfaces of the majority of 
healthy human individuals. However, the fungus can cause superficial infections in otherwise healthy 
people and could develop life-threatening systemic candidiasis in immunocompromised patients. 
Mucosal epithelial cells can discriminate the shift from the commensal to the pathogenic lifestyle of 
C. albicans by the activation of a biphasic MAPK mediated by PRRs. Previous studies mainly focused 
on the mucosal cytokine response from oral and vaginal epithelial cells that can be affected by 
superficial infections. This study aimed to compare the cytokine release from oral mucosal epithelial 
cells with parenchymal hepatic and renal epithelial cells. While all three tested cell lines released IL-
6 and IL-8 in response to C. albicans-induced cell damage, secretion of other inflammatory cytokines 
was cell line-specific. The PRR-mediated damage-dependent cytokine secretion suggested an 
epithelial-specific expression of PRRs. However, all cell lines expressed a similar pattern of TLR2, TLR4, 
dectin-1, dectin-3, and MR that were not inducible by C. albicans infection or stimulation with 
cytokines. Different responsiveness of PRR stimulation with ligands and the epithelial-specific 
cytokine release further suggested an epithelial-specific induction of signaling cascades downstream 
of PRRs. Indeed, MKP1 phosphorylation displayed cell-specific kinetics that were independent of early 
host cell damage. The epithelial immune response can be modulated by C. albicans factors that was 
observed during a large-scale host response screening. This study focused on Mnn9 that is crucial for 
the N-mannosylation of the cell wall and therefore has an influence on host recognition. A deletion 
in the MNN9 gene induced stronger inflammatory cytokine releases by hepatic and oral epithelial 
cells without altering the damage potential. Using a set of mannosylation mutant strains, the 
influence of the glycosylation status of C. albicans cell wall on epithelial damage and cytokine 
induction was further analyzed. Compared to the MNN9 mutant a similar phenotype in the epithelial 
immune response was observed for the MNN2 sextuple mutant. To activate the epithelial immune 
response adhesion to host cells is considered as a prerequisite step. However, the MNN9 mutant 
adhered weaker on hepatic cells and was less invasive in all tested cell lines, suggesting a more 
complex interaction of different fungal factors with epithelial cells. The MNN9 mutant induced an 
elevated oral IL-1α and IL-1β release that was partly dependent on the IL-1 receptor but independent 
of the NRLP3 inflammasome. Notably, the release of inflammasome-associated cytokines was only 
observed in oral but not renal or hepatic epithelial cells. Differences observed in the epithelial 
cytokine response by different glycosylation statuses of the cells suggested an altered PAMP 
exposure. However, all tested strains displayed a similar and strong surface exposure of β-1,3-glucan 
and chitin. While the process of the epithelial receptor-mediated recognition of C. albicans is still 
unknown, previous findings in this study suggested differences in the activation of MAPK signaling 
causing elevated cytokine releases induced by the MNN9 mutant. Interestingly, while the MNN9 
mutant induced a delayed activation of oral MKP1 as well as of ERK1/2 and JNK, consistent 
phosphorylation indicates stronger and prolonged activation of all three MAPK pathways during 
infection that could explain the increased cytokine release. A mouse model of disseminated 





intact mannosylation layer of the C. albicans cell wall. Taken together, this study could show that the 
epithelial immune activation in response to C. albicans differs not only between mucosal and 
parenchymal cells, it is also cell type-specific. Moreover, the cytokine secretion can be modulated by 







Der opportunistische Pilzpathogen Candida albicans besiedelt die Schleimhäute bei der Mehrzahl der 
gesunden Individuen. Der Pilz kann jedoch Oberflächeninfektionen im ansonsten gesunden 
Menschen auslösen, sowie lebensbedrohliche, systemische Candidosen in immungeschwächten 
Patienten entwickeln. Mukosale Epithelzellen sind in der Lage, eine Veränderung vom kommensalen 
hin zum pathogenen Lebenszyklus von C. albicans mit Hilfe der Mustererkennungsrezeptoren (PRR) 
zu unterscheiden und ein zweistufiges Signalkaskadesystem (MAPK) zu aktivieren. Vorhergehende 
Studien fokusierten sich hauptsächlich auf die mukosale Zytokinantwort von oralen und vaginalen 
Epithelzellen, die durch Oberflächeninfektionen betroffen sein können. Diese Studie zielte darauf ab, 
die Zytokinsekretion von oralen, mukosalen Epithelzellen mit der von parenchymalen, hepatischen 
und renalen Epithelzellen zu vergleichen. Während alle drei getesteten Zelllinien IL-6 und IL-8 als 
Reaktion auf die von C. albicans-induzierte Schädigung freisetzen, wurden andere inflammatorische 
Zytokine zelltypspezifisch sekretiert. Die PRR-vermittelte und schädigungsabhängige 
Zytokinsekretion suggerierte eine epithelspezifische Expression von PRRs. Jedoch exprimierten alle 
Zelllinien ähnlich viel TLR2, TLR4, Dectin-1, Dectin-3 und MR, welche durch Infektion mit C. albicans 
oder Stimulierung mit Zytokinen nicht stärker induziert werden konnten. Die unterschiedliche 
Stimulierbarkeit von PRRs mittels Liganden und die epithelspezifische Zytokinfreisetzung legten nahe, 
dass es zu einer unterschiedlichen Aktivierung von Signalkaskaden kommt. Tatsächlich erfolgt eine 
MKP1-Phosphorylierung zeit- und zelltypspezifisch, ist jedoch unabhängig von einer frühen 
Zellschädigung. Die Immunantwort von Epithelzellen kann durch C. albicans-Faktoren reguliert 
werden, welche im Rahmen eines Screenings der Wirtsimmunantwort analysiert wurde. Diese Studie 
fokussierte sich auf den Faktor Mnn9, welcher einen entscheidenden Einfluss auf die N-
Mannosylierung der Zellwand hat und deshalb auch direkt die Erkennung durch den Wirt beeinflusst. 
Ein Defekt im MNN9-Gen führte zu einer stärkeren Freisetzung inflammatorischer Zytokine durch 
hepatische und orale Epithelzellen, ohne das Schädigungspotential im Vergleich zum Wildtyp zu 
verändern. Durch die Verwendung einer Kollektion von verschiedenen Mannosylierungsmutanten 
wurde der Einfluss des Glykosilierungsstatus der C. albicans-Zellwand auf die Schädigung und 
Zytokinfreisetzung von Epithelzellen weitergehend untersucht. Im Vergleich zur MNN9-Mutante 
wurde ein ähnlicher Phänotyp in der Immunantwort von Epithelzellen bei der MNN2-
Sechsfachmutante beobachtet. Um eine Immunantwort von Epithelzellen zu induzieren, wird 
angenommen, dass die Adhäsion an Wirtszellen eine Grundvoraussetzung darstellt. Die MNN9-
Mutante jedoch adhärierte schwächer an hepatischen Zellen und war weniger invasiv in allen drei 
getesteten Zelllinien gewachsen, was mutmaßlich durch ein komplexes Zusammenspiel aus 
verschiedenen Pilzfaktoren mit Epithelzellen hervorgerufen wird. Außerdem induzierte die MNN9-
Mutante eine erhöhte IL-1α- und IL-1β-Sekretion von oralen Epithelzellen, die teilweise vom IL-1-
Rezeptor abhängig war, jedoch unabhängig vom NLRP3-Inflammasom. Auffallend war, dass 
Inflammasom-assoziierte Zytokine nur von oralen, und nicht von renalen und hepatischen 
Epithelzellen freigesetzt wurden. Die durch einen veränderten Glykosylierungsstatus der Zellen 





von C. albicans ein verändertes Pathogen-assoziiertes, molekulares Muster (PAMPs) exponiert. Alle 
getesteten Stämme zeigten jedoch eine ähnliche sowie stark erhöhte Exponierung von β-1,3-Glukan 
und Chitin. Zwar ist der Prozess der Rezeptor-basierten Erkennung von C. albicans weiterhin 
unbekannt, die vorangegangenen Ergebnisse dieser Studie deuten jedoch auf eine unterschiedliche 
Aktivierung des MAPK-Signalweges, das wiederum zur erhöhten Zytokinfreisetzung durch die MNN9-
Mutante führte. Interessanterweise stellte sich dabei heraus, dass es zu einer verzögerten 
Aktivierung von MKP1, ERK1/2 und JNK in oralen Epithelzellen durch die MNN9-Mutante kommt. Eine 
kontinuierlich ansteigende und über einen längeren Zeitraum anhaltende Phosphorylierung aller drei 
Signalkaskaden könnte jedoch die zuvor beobachtete, erhöhte Zytokinfreisetzung erklären. 
Weiterhin stellte sich heraus, dass im systemischen Candidose-Model der Maus, die MNN9-Mutante 
eine stark reduzierte Virulenz aufweist. Dadurch wird deutlich, dass eine intakte Mannosylierung der 
Zellwand wichtig für die Pathogenität ist. Zusammengefasst kann gesagt werden, diese Arbeit konnte 
zeigen, dass die Immunantwort von Epithelzellen in Bezug auf C. albicans-Infektionen nicht nur davon 
abhängt, ob die Epithelzellen aus der Schleimhaut oder dem Parenchym innerer Organe stammen, 
sondern zelltypspezifisch ist. Die Zytokinsekretion kann zudem durch die Veränderung der pilzlichen 








3.1 The human pathogen Candida albicans 
Fungi are ubiquitously distributed and represent approximately 7% of all species on earth 1. Some of 
them substantially contribute to life-threatening human infections that cause high mortality rates 
including the genera Cryptococcus, Aspergillus, Pneumocystis, and Candida 2. From more than 150 
known Candida species, 15 of them are opportunistic human pathogens with C. albicans, C. glabrata, 
C. parapsilosis, C. tropicalis, and C. krusei frequently isolated 3. In contrast to other fungal pathogens, 
some Candida species and in particular C. albicans and C. glabrata are commensals of the human 
microbiota colonizing mucosal surfaces 4. 
3.1.1 Clinical relevance 
C. albicans is a harmless member of the endogenous human mycobiota of about 30-70% of healthy 
individuals and colonizes mucosae of the urogenital- and gastrointestinal tract and oropharynx 4. The 
lifestyle of C. albicans can shift from commensal to pathogenic affecting immunocompromised but 
also immunocompetent individuals and occurs in neonatal intensive care 2,5. Life-threatening 
systemic candidiasis can develop through the breakdown of gastrointestinal barriers, in patients with 
immunosuppression, or is associated with the use of medical devices such as central venous catheters 
6. Candida spp. are the fourth most common cause of nosocomial bloodstream infections with the 
highest incidence of C. albicans 3,7,8. Candidaemia-caused crude mortality ranges from >20% observed 
in German ICU’s 7 up to 49% at ICU’s in the United States of America 9,10. Early fungal-specific diagnosis 
is limited, resulting in delayed or inappropriate antifungal therapy. Besides that, antifungal drugs that 
directly target fungal virulence factors such as C. albicans dimorphism are not available 11. Currently, 
classes of polyenes, azoles, and echinocandins are applied in antifungal prophylaxis. These 
antifungals, however, are often fungistatic that gives the fungus time to develop resistance 12. Azoles 
(e.g. fluconazole, voriconazole) and polyenes (e.g. amphotericin B) target ergosterol formation that 
is a major component of the fungal cell membrane, while echinocandins (e.g. caspofungin) target the 
cell wall by inhibiting the β-1,3-glucan synthase 13. Even though the prevalence of resistant strains to 
fluconazole increases, this antifungal is most commonly administered to patients suffering from 
bloodstream infections 10. Nevertheless, resistance to the newest, clinical approved antifungal class 
of echinocandins has also been reported in recent years 14. 
3.1.2 Mucosal infections 
While systemic infections caused by C. albicans display very high mortality rates, much higher 
morbidity rates are caused by superficial infections affecting the oral cavity and vaginal tract that 
usually do not lead to death 2,15. 
Thrush or oropharyngeal candidiasis (OPC) affects worldwide 10 million people annually. Particularly 
common risk factors for OPC are immunosuppression, e.g. by HIV, but also cancer, transplantations, 
antibiosis, and the uses of dentures 16. OPC is characterized by the invasion of epithelial cells from 





The most prevalent form of Candida infection is vulvovaginal candidiasis (VVC) affecting 50-75% of 
immunocompetent women at least once in their lifetime 18. One-tenth of them further develop 
recurrent or chronic VVC suffering at least four episodes annually 18. Yeast cells of C. albicans are 
often isolated from healthy women indicating that this morphology is tolerated by the host. In 
contrast to OPC, C. albicans induced inflammatory cytokines that recruit neutrophils are detrimental 
to vaginal immunopathology. This immune cell recruitment during VVC induces an overwhelming 
immune response that worsens inflammation without reducing fungal burden 19. 
Due to its high prevalence, both superficial fungal infections have been studied in different in vitro 
models such as monolayer cell cultures (oral epithelial cells, vaginal epithelial cells) or reconstituted 
human epithelium (oral RHE and vaginal RHVE 20,21) and mouse models of OPC 22 and VVC 23. To 
investigate C. albicans virulence in systemic infections the mouse intravenous challenge model is 
most commonly used. 
3.1.3 Morphological plasticity 
C. albicans is a polymorphic fungus that can grow as unicellular yeast, pseudohyphae or true hyphae 
24. It can switch between these morphotypes that enables colonization of the host (yeast) and 
invasion (filaments). This morphological plasticity is a critical step in C. albicans pathogenicity but not 
in non-filamenting C. glabrata and C. parapsilosis. Filamentation in C. albicans is mediated by the core 
response of eight gene products including the cell wall-associated proteins Als3, Ece1, Hwp1, and 
Rbt1 25 and involves transcription factors such as Rfg1 26. The thigmotropic orientation of growing 
filaments further facilitates C. albicans to invade and damage host cells 27. Different cell morphologies 
have a divergent influence on the host immune response. While C. albicans yeast cells induce a strong 
cytokine response of human PBMCs, pseudohyphae and hyphae induce a weaker innate immune 
response 28. In contrast, C. albicans hyphae induce a stronger TNF-α response in macrophages 29, and 
induce more cytokines in oral and vaginal epithelial cells 30,31 than yeast cells. The shift of different 
environmental signals are considered to initiate or affect filamentation, e.g. the presence of N-
acetylglucosamine, or serum, neutral pH, CO2, temperature, the presence of quorum sensing 
molecules such as farnesol, and nutrients availability 32,33. Following hyphal initiation, hyphal 
maintenance is also important in virulence mediated by the C. albicans factor Eed1 34. 
3.1.4 Stages of pathogenesis 
In order to cause fungal disease, three stages of pathogenesis can be discriminated in the shift from 
a commensal to a pathogenic lifestyle of C. albicans 35: adhesion, invasion, and host cell damage. 
Some factors that are involved in these stages have functional redundancy that cannot distinctly be 
separated. Besides this, C. albicans is continuously interacting with the host also in the commensal 
phase, and therefore adhesion only is not an intrinsic characteristic of pathogenesis. The majority of 
human mucosae are comprised of epithelial cells that coat outside surfaces of organs or the human 
body 36. Therefore, these epithelial cells stay in direct contact with the outlining microbial 






Adhesion is mediated through fungal cell wall moieties that interact with host cell receptors to allow 
a covalent attachment 37. Fungal Als3 (agglutinin-like sequence 3) and Ssa1 interact with surface 
expressed E-Cadherin and EGFR/HER2 (epidermal growth factor receptor/human epidermal growth 
factor 2) expressed by oral cells 38. Other fungal adhesion proteins include Eap1 (enhanced adhesions 
to polystyrene), Iff4, and Hwp1 (hyphal wall protein 1) that interact with epithelial cells but the 
epithelial-mediated recognition is unknown. The initial contact to host cells is likely mediated by yeast 
cells, while a morphological switch from yeast to hyphae induces the expression of more adhesins 
that confers stronger adhesion 39. Following adhesion, a strong induction of hypha formation occurs 
in less than one hour in vitro and is accompanied with the expression of hypha-associated proteins 
that are involved in further adhesion, invasion, and host cell damage that ultimately result in immune 
activation 40. Opposing roles in epithelial adhesion has been observed for different members of the 
Als family of cell surface adhesins: while disruption of ALS2 41 and ALS3 42 reduces epithelial adhesion, 
deletion of ALS5, ALS6, or ALS7 leads to increased adhesion 43. 
Invasion into host cells is hypha-dependent and can occur by host-driven induced endocytosis that 
does not require viable hyphae, or fungal-driven active penetration 44. Receptor-mediated induced 
endocytosis is a critical step in OPC and requires the interaction of fungal Als3 and Ssa1 with host E-
cadherin 45 and the receptors EGFR/HER2 38 that causes remodeling of the actin cytoskeleton, and the 
downstream AhR (aryl hydrocarbon receptor) 46. This invasion route, however, occurs in oral 47 but 
not in intestinal epithelial cells 48,49. The more prevalent invasion strategy in distinct cell types is 
believed to be active penetration 47 that relies on fungal turgor pressure and secreted proteinases 
from the Sap family 50–52. Disruption of SAP genes has been demonstrated to impair both fungal 
invasion and adhesion properties with a reduced adhesion caused by a deletion of SAP1, SAP2, SAP3, 
and SAP10, and increased adhesion caused by a deletion of SAP9 53,54. Compared to induced 
endocytosis, active penetration occurs at later time points during infection in vitro. However, oral 
mucosa is comprised of an outermost layer with terminally differentiated cells and an underlying 
layer with proliferating epithelial cells that require both processes to facilitate fungal invasion and to 
establish infection 37. 
Damage of host cells is caused by fungal hyphae during deep invasion and is accompanied by the 
secretion of hydrolases 55. Recently, fungal-induced epithelial damage was directly linked with the 
secretion of Candidalysin, an Ece1-derived peptide toxin 17,56 that intercalates into membranes 
causing lesions. Translocation from mucosal surfaces into the bloodstream can cause life-threatening 
fungal disease, however, this does not necessarily induce host cell damage 49. Damage of oral 
epithelial cells induced by C. albicans can occur via necrosis or apoptosis 57,58. Translocation through 
the intestinal barrier is induced by necrosis only 49. 
3.2 The cell wall of Candida albicans 
3.2.1 Composition and genes involved in cell wall synthesis 
The fungal cell wall equally provides rigidity to convey the cell shape and flexibility to enable cell wall 





of the three major polysaccharides mannan, β-glucan, and chitin (Fig. 1). Compositions of cell wall 
polysaccharides vary between strains and conditions, however, about 60% are β-glucans, 35-40% 
mannoproteins, and 1-2% chitin 59. β-1,3-glucan is covalently linked to chitin within the inner layer 
and to mannoproteins of the fibrillary outer cell wall layer via β-1,6-glucan. These mannoproteins are 
connected via glycosylphosphatidylinositol (GPI)-anchors to β-glucans or to the cell membrane. 
Cell wall proteins are post-translationally modified through the addition of N- and O-linked mannans 
59 that are (besides β-glucan and chitin) important pathogen-associated molecular patterns (PAMPs) 
recognized via host pattern recognition receptors (PRRs). Linear O-linked glycosylation consists of α-
1,2-mannose residues and requires gene activity of MNT1, MNT2, members of the PMT family, and 
indirectly PMR1 60. O-linked glycosylation is required for mucosal adhesion and virulence in murine 
disseminated candidiasis 61–63. 
Fig. 1. Candida albicans cell wall structure. 
The C. albicans cell wall consists of an inner layer of β-glucan and chitin, and an outer layer made of N- 
and O-linked mannans that are linked with proteins. Modified from Gow et al., 2012 82. 
Fig. 2. Involvement of polymerase I and II in the N-mannan backbone biosynthesis. 
The mannosyltransferase Och1 catalyzes addition of the first α-1,6-mannosyl residue to the N-mannan 
core. Further elongation of the backbone is performed by the polymerase I and II complex. Decoration of 
the backbone with different sidechains mainly involves the activity of members from the Mnn1 and Mnn2 





Complex branched N-mannosylation is important in the fungal-epithelial interaction inducing a host 
response and is required for full virulence 60. The N-glycosylation structure can be divided into the N-
mannan core that branches into the backbone and sidechains. Synthesis of N-linked glycans has been 
studied in the nonpathogenic Saccharomyces cerevisiae 64, and many related genes found in C. 
albicans are orthologues with an equal activity. The process of mannosylation starts with the 
formation of the N-mannan core during protein synthesis in the lumen of the endoplasmic reticulum 
65,66. The core consists of a dolichol pyrophosphate anchored oligosaccharide Glc3Man9GlcNAc2 that 
is transferred onto asparagine residues within the polypeptide 67. After processing by glycosidases, 
the mature core Man8GlcNAc2 is formed that is essential for the outer chain of branched N-mannan. 
Further attachments of mannose are then performed by mannosyltransferases in the Golgi 
apparatus. The N-mannan backbone synthesis starts with the first α-1,6-mannosyl residue added to 
the core by the mannosyltransferase Och1 68 (Fig. 2). Then, the polymerase I complex composed of 
the mannosyltransferases Mnn9 and Van1 form the first part of the α-1,6-mannose backbone of 
about 10 α-1,6-mannosyl residues 69,70. This backbone is further extended by the mannan polymerase 
II complex composed of Mnn9 and Anp1 71. Recently, Mnn10 was identified as another important 
subunit of the mannan polymerase for the extension of the α-1,6-mannose backbone 72. The 
backbone is decorated by sidechains of α-1,2-mannose and involves gene activity of MNN5 73,74 and 
members of the MNN2 family (MNN2, MNN21, MNN22, MNN23, MNN24, MNN26). Sequential 
deletion of MNN2 genes results in altered cell wall composition, enhanced sensitivity against cell wall 
stressors, and attenuation in virulence, with the most severe phenotype when all members are 
deleted in a MNN2 sextuple mutant 75. The addition of α-1,2-mannosyl sidechains can also be 
performed by Mnt5, showing a functional redundancy in the highly branched N-mannosylation 76. 
Outer chains are further capped with either β-1,2-mannose by Bmt1 and Bmt3 77, or α-1,3-mannose 
units by members of the MNN1 gene family (MNN1, MNN12, MNN13, MNN14, MNN15, MNN16). 
While the gene products of the MNN1 family are considered to display functional redundancy, 
deletion of MNN14 results in avirulence in murine disseminated candidiasis and is associated with 
only subtle defects in mannosylation 78. 
Further branching of the α-1,2-mannose sidechains occurs by adding phosphomannan through a 
phosphodiester bond via Mnn4 and Mnn6 79 and is required for macrophage phagocytosis 80. 
Glycosylation elaborated by mannosyltransferases in the Golgi apparatus requires manganese ions 
as an essential cofactor 74. The P-type ATPase Pmr1 is involved in calcium and manganese ion 
transport into the Golgi apparatus maintaining manganese homeostasis. Therefore, disruption of 
PMR1 impairs the general activity of mannosyltransferases influencing N- and O-mannosylation that 
leads to attenuated virulence in mice 81. Experimentally determined N- and O-glycosylation structures 
75 show that a pmr1Δ/Δ strain displays less severe defects compared to an och1Δ/Δ strain. However, 
the structure of both mutants is most impaired followed by mnn9Δ/Δ, mnn2Δ/Δ sextuple, single 
mnn2Δ/Δ, and mnn1Δ/Δ. 
Underneath the mannoprotein layer, the inner skeletal cell layer consists of β-glucans and chitin that 





synthesized by β-1,3-glucan synthase complex consisting of the catalytic subunit Fks1, Gsl1, and the 
regulatory subunit Rho1 83. It is an important antifungal target by inhibiting the β-1,3-glucan synthesis 
with the antifungal drug echinocandin 13. Exposure of β-1,3-glucan at yeast bud scars induces a strong 
inflammatory cytokine response in immune cells and triggers C. albicans phagocytosis that is 
recognized by dectin-1 and TLR2 84. Unmasking of the glucan layer by heat inactivation, antifungal 
drugs, during the progression of infection, or defects in the mannan layer by gene deletions further 
increases the immunostimulatory effect 85. Masking the immune activating β-1,3-glucan from the 
immune system has also been observed by other fungi, e.g. Histoplasma capsulatum 86. 
Cell wall chitin counts for about 2% of the total cell wall composition in yeast 87, while hyphae contain 
five times more chitin 88. Chitin is a polymer of β-1,4-GlcNAc that is synthesized by the chitin synthases 
Chs1, Chs2, Chs3, Chs8 89. However, only Chs1 is essential for C. albicans viability 90. While Chs3 is 
responsible for about 85% of yeast and hyphal cell wall chitin, Chs2 is hypha-specific 91. Similar to β-
glucan, chitin is only exposed at bud scars 84 and unmasking can be induced by heat and echinocandins 
but also during neutrophil attack 92. The immune recognition of chitin is so far not resolved 93, but 
chitin of specific molecular sizes can induce a cytokine response in macrophages that involves NOD2, 
TLR9, and MR 94,95. 
3.2.2 The Candida albicans mannosyltransferase Mnn9 
Cell wall mannosylation is critical in host recognition and immune activation of myeloid and epithelial 
cells. The C. albicans gene MNN9 (ORF19.7383) is an ortholog of S. cerevisiae MNN9 that is 1107 bp 
long (Candida Genome Database, C. albicans Assembly 22). The gene product encodes for a subunit 
of the mannosyltransferase complex in the Golgi apparatus that elongates the α-1,6-mannose 
backbone of the N-mannosyl residue. Its role in glycosylation and modification of secreted proteins 
was first described in S. cerevisiae 96 and later in C. albicans 97. MNN9 is expressed in yeast and hyphae 
with highest rates during filament-inducing conditions (thesis of Carlos Cívicos Villa, 2014; 
https://gredos.usal.es/jspui/handle/10366/125512). Deletion of MNN9 results in aggregates of 
slightly larger yeast cells and, depending on the study, results in formation of pseudohyphae 97 or 
normal hyphae 98 under filament-inducing conditions. In accordance with other mannosylation 
mutant strains, the cell wall composition of a MNN9 deletion strain displays reduced mannan but 
elevated β-glucan levels 97,99. As a consequence, the cell wall integrity is affected, and the mutant 
shows increased sensitivity to Congo Red 99, fluconazole, amphotericin B, and itraconazole (thesis of 
Carlos Cívicos Villa, 2014). A deletion of MNN9 further impairs biofilm formation at later time points 
100 and decreases the adhesion capability on oral epithelial cells 98. Fungal factors that are commonly 
expressed in C. albicans to enable adhesion, invasion, and damage of host cells (e.g. members of the 
Als and Sap family, Ssa1, Ece1) show no obvious differences in expression compared to the wild type  
17,97,100. Impaired N-glycosylation caused by deletion of MNN9 enables this strain to damage oral 
epithelial cells and activates MKP1 and c-Fos which results in the release of the inflammatory 
cytokines G-CSF, GM-CSF, IL-1a, and IL-6 98. In contrast to many other mannosylation mutant strains, 






3.3 Interaction of Candida albicans with epithelial cells 
In order to prevent invasion of pathogenic microorganisms, the human body has evolved a set of 
immune responses that include physical barriers and the activation of an innate and adaptive immune 
system. Epithelial cells at mucosal surfaces are constantly exposed to the external environment and 
represent physical barriers that are not only passive in function but rather constitute the first line of 
defense 36. Moreover, epithelial cells are also part of the parenchyma of internal organs, such as 
kidney and liver. In the past years, epithelial cells are considered as active sensors in the innate 
immunity that differ from the myeloid immune response mechanisms to recognize, signal, and secret 
immune effectors in response to fungal infection. 
3.3.1 Different recognition by myeloid and epithelial cells 
The innate immune response of invading C. albicans has been extensively studied and is 
predominantly mediated by neutrophils, monocytes, macrophages, and dendritic cells that requires 
recognition of conserved microbial signatures 101. Recognition of these so-called PAMPs is 
accomplished by the major classes of PRRs including TLRs (toll-like receptors), CLRs (C-type lectin 
receptors), and NLRs (nucleotide-binding oligomerization domain (NOD)-like receptors) 101,102 (Fig. 3). 
TLRs are transmembrane receptors that recognize bacterial, viral, and fungal PAMPs via an 
extracellular LRR domain (leucine-rich repeat), and signal into the cytoplasm via a TIR domain 
(Toll/interleukin-1 receptor) 103. CLRs recognize PAMPs via an extracellular CRD (carbohydrate-
recognition domain) or CTLD (C-type lectin-like domain) and signal through the cytoplasmic 
ITAM/ITIM (immunoreceptor tyrosine-based activation/inhibition motif) 104. NLRs recognize both 
Fig. 3. Pattern recognition receptors that are involved in the recognition of C. albicans pathogen-
associated molecular patterns. 
Toll-like receptors and C-type lectin receptors extracellularly recognize C. albicans cell wall components 






pathogen-associated pattern and host-derived molecules. Together with ASC (apoptosis-related 
speck-like protein containing a CARD) and procaspase-1 they form the inflammasome that activates 
caspase-1 resulting in the cleavage of pro-IL-1β and pro-IL-18 into their mature and active form 105. 
Another class that recognize C. albicans involves galectin-3 106. 
PRRs from different classes can recognize C. albicans cell wall polysaccharides such as mannans, β-
glucan, and chitin. Immune sensing of C. albicans by monocytes and macrophages is mediated by the 
recognition of N- and O-linked mannans and β-glucan that requires CLRs and TLRs involving MR 
(mannose receptor), TLR4 and the dectin-1/TLR2 complex 102,107. Apart from MR, dectin-2 has also 
been described to recognize N-linked mannan 108, while TLR4 only recognizes O-linked mannan 107. β-
glucan is thought to be masked by the fibrillary mannan layer, and its exposure is restricted to bud 
scars or occurs during cell wall rearrangement in the process of hyphae formation and infection 84,85. 
However, recent findings doubt the static view of the cell wall and suggest at least partial surface 
exposure of β-glucan 109. Recognition of β-glucan involves the complement receptor CR3, TLR2, TLR6, 
and the CLR dectin-1 107,110. Because of the predominant exposure of β-1,3-glucan at bud scars dectin-
1 is considered to recognize only C. albicans yeast but not hyphal cells 84. Recently, the non-classical 
receptor for β-glucan EphA2 (ephrin type-A receptor 2) was discovered on oral epithelial cells that 
sense the presence of both yeast and hyphae 111. Likewise β-glucan, chitin lines the inner skeletal 
layer of C. albicans cell wall and is rarely exposed to surfaces 84, but unmasking can occur during 
neutrophil attack 92. Macrophages are able to recognize chitin and induce an inflammatory cytokine 
response depending on the size of the molecule 94. Recently, TLR2 has been identified to directly bind 
fungal chitin in a size-dependent manner 237. Previous studies also suggested involvement of NOD2, 
TLR9, and MR in chitin recognition 95. Furthermore, the intracellularly expressed TLR9 senses 
microbial DNA 112. 
Many epithelial cells also constitutively express TLRs, CLRs, and NLRs with some contrary results 
depending on the study. In contrast to myeloid cells, type and composition of PRRs vary between 
primary cells and cell lines, mucosal localization, and species. The majority of TLRs are expressed by 
many epithelial cells such as the oral epithelium 113, intestinal, lung, and hepatic cells 106. The role of 
epithelial TLRs in the epithelial activation has been questioned 114, however, stimulation of TLRs with 
microbial ligands induces antimicrobial peptides and cytokines indicating a functional role in the 
epithelial immune response 106. Even though oral cells express only low levels of TLR4, it is required 
for an epithelial activation once neutrophils are recruited, resulting in immunological crosstalk 
between the epithelium and immune cells to protect from C. albicans infection 113. It, therefore, 
appears that some PRRs are not required for the initial recognition but mediate antifungal protection 
in the presence of neutrophils 106. 
In contrast to TLRs, only a few reports have described the expression of epithelial CLRs including the 
expression of dectin-1 in bronchial and intestinal epithelial cells 115,116. Non-PRRs may also be involved 





3.3.2 Discrimination between commensal and pathogenic Candida albicans 
The identification and discrimination of endogenous, opportunistic colonizers from pathogenic 
microbes is a fundamental ability of mucosal epithelial cells 106 (Fig. 4). Recognition of microbial 
PAMPs leads to PRR signaling and downstream activation of MAPK (mitogen-activated protein kinase) 
and NF-kB (nuclear factor kappaB) pathways 30,31. Once activated, MAPK signaling results in the 
release of chemokines, inflammatory cytokines, and antimicrobial peptides that clear infection or 
further activate the innate and adaptive immunity 106. Therefore, the activation of MAPKs is a tightly 
regulated process to enable a fine-tuned immune response to prevent overreaction 117. Colonizing 
yeast cells of C. albicans are recognized by conventional PRRs that induce a weak and transient 
activation of NF-kB, Pi3K (phosphatidylinositol-4,5-bisphosphate 3-kinase), and the MAPK pathways 
p38, JNK (c-Jun N-terminal kinase), and ERK1/2 (extracellular signal-regulated protein kinase), 
independent of fungal viability 30. Induction of these pathways occurs within 15 min in oral epithelial 
cells and induces further activation of the transcription factor c-Jun via JNK and ERK1/2 pathways. 
The activation of c-Jun, however, represents a non-inflammatory epithelial response without 
cytokine secretion 30. During mucosal infection, hyphal formation and epithelial invasion, as well as 
an increasing fungal burden, lead to sustained activation of NF-κB and PI3K signaling pathways and 
further increases MAPK signaling by the activation of the transcription factor c-Fos via p38 30,31,118,119. 
Fungal invasion also activates the MAPK phosphatase MKP1 that is induced and stabilized by ERK1/2. 
Mucosal activation of c-Fos and MKP1 regulation depend on hypha formation and correlate with cell 
damage and the induction of epithelial inflammatory cytokines 30,118. Strains that are not able to 
produce or maintain hyphal formation do not induce an epithelial cytokine response. In addition to 
Fig. 4. Mucosal epithelial cells discriminate between colonizing yeast cells and invading hyphae. 
Colonizing yeast cells activate transient signaling that does not result in an epithelial cytokine secretion 
(left site). When C. albicans filaments, reaches high levels of fungal burdens, and invades epithelial cells, 
a second MAPK signaling pathway including c-Fos and MKP1 is activated that induces an inflammatory 





the triggered danger response, infection of oral mucosa also induces damage protection via 
PI3K/mTOR signaling pathway 119. 
The MAPK p38/c-Fos signaling mechanism is considered as a common mucosal epithelial danger 
response activated during dangerous levels of invasive hyphae 30,99. However, the induced cytokine 
response is site-specific, and the threshold of hyphal burden differs between oral and vaginal cells. 
While oral epithelial cells secrete IL-1α, IL-1β, G-CSF, GM-CSF, IL-6, and IL-8 in response to C. albicans 
infection 30, secretion of G-CSF and IL-6 is almost absent by vaginal epithelial cells 31. These cytokines 
stimulate neutrophil generation and activation from granulocyte-macrophage progenitors in the 
bone marrow 120. Neutrophils are the principal effector cells to clear C. albicans infection by 
phagocytosis 121. They also interact with epithelial cells to provide mucosal protection. Phagocytosed 
C. albicans cells are killed intra- or extracellularly by reactive oxygen or nitrogen species (ROS and 
RNS), and by neutrophil extracellular traps (NETs) released during neutrophil cell death 122,123. This 
protective role of neutrophils in oral candidiasis is detrimental in vaginal candidiasis as overt 
inflammation exacerbates disease 124. Besides the epithelial cytokine response, antimicrobial 
peptides such as defensins (β-defensin-1/2/3), cathelicidins (LL-37), and histatins (histatin-5) are 
released from oral epithelial cells to limit fungal growth 125. The interaction of epithelial cells with 
immune cells has been demonstrated for the PMN-dependent secretion of epithelial antimicrobial 
peptides that is important in the clearance of C. albicans in oral mucosal infection 113,126. In addition, 
the mucosal epithelial immune response also induces protective adaptive immunity by recruiting 
CCR6-expressing dendritic cells that phagocyte C. albicans and present antigens to T cells 127. IL-17A/F 
secreted by Th17 cells acts on mucosal epithelial cells to support barrier function and to induce 
epithelial antimicrobial peptides such as β-defensin-3 128,129, but neutrophil mobilization is 
independent of the IL-17 pathway 130. 
3.3.3 Role of the inflammasome in the host response 
Inflammasomes are intracellular multiprotein complexes composed of a sensor PRR of the NLR family, 
in some cases an ASC adaptor protein (apoptosis-related speck-like protein containing a CARD), and 
the cysteine protease procaspase-1 105. Sensor proteins are NLRP1, NLRP3, NLRC4, NLRP6, and AIM 
(absent in melanoma 2) that can recognize both pathogen-associated patterns and host-derived 
molecules. C. albicans, however, is only recognized by the inflammasomes NRLP3 and NLRC4 131,132. 
The canonical NLRP3 inflammasome is expressed in myeloid cells and nonkeratinizing epithelial cells 
from the oral cavity and is by far the best-characterized inflammasome 133,134. Formation of the 
inflammasome activates procaspase-1 into caspase-1 that is responsible for the cleavage of pro-IL-1β 
and pro-IL-18 into their mature secreted form. To activate the NLRP3 inflammasome, priming and 
activation signals are required 135–137. In the initial step, activation of the transcription factor NF-κB by 
upstream PRRs such as TLRs, the IL-1 receptor IL-1R1, and TNFR leads to the transcription and 
translation of pro-IL-1β and NLRP3. In a second step, a diverse group of agonists such as cytokines, 
pore-forming toxins, ATP, and crystalline molecules lead to the activation of NLRP3 138–140, the 
assembly of the NLRP3 inflammasome, and consequently the activation of caspase-1. In 





induces IL-1β secretion 131,136 or a cytokine-dependent programmed cell death called pyroptosis 141.  
IL-1β is mainly produced by macrophages and is important in the acute phase response during 
infection by recruiting neutrophils and monocytes, and induces additional cytokines 142. The presence 
of host molecules released by injured cells causing sterile inflammation, can also activate the 
inflammasome that leads to the production of pro-inflammatory IL-1β 143. Both cytokines from the IL-
1 family, IL-1β and IL-1α, the latter which is released during cell death 138, bind to the IL-1 receptor 
and induce their own production and secretion via a positive feedback loop. IL-1R signaling regulates 
the neutrophil response and plays a critical role in the defense of OPC 144. 
 




4 Aims of this study 
Disseminated candidiasis in mice revealed that the kidney is the principal target organ accompanied 
by a low number of resident immune cells and delayed neutrophil recruitment 145,146. However, 
inflammatory cytokines appear early during infection and correlate with the immunopathology in the 
kidney 147. In contrast, early accumulation of neutrophils in the liver controls C. albicans fungal 
burden. This organ-specific control of C. albicans assumes an contribution of epithelial cells to the 
progression of disease.  
Previous studies about the epithelial cytokine response focused on mucosal sites that can be affected 
by superficial C. albicans infection resulting in OPC or VVC. Mucosal epithelial cells can discriminate 
between yeast and hyphal forms of C. albicans that requires PRR signaling and downstream activation 
of the MAPK pathway. This activation is mediated by MKP1 and c-Fos that depends on C. albicans 
hyphal formation and host cell damage 30,31,118.  
During systemic infection almost all organs can be affected by C. albicans. Thus, the fungus also 
interacts with epithelial cells that are part of the parenchyma of internal organs, e.g. from kidney, 
spleen, and liver. While parenchymal epithelial cells are usually sterile, mucosal epithelial cells are in 
direct contact with the invading pathogen. This suggests that both types of epithelial cells differently 
activate an innate immune response. Therefore, this study aimed to analyze and to compare the 
cytokine induction from mucosal and parenchymal epithelial cells. 
C. albicans can bypass the host immune system by metabolic adaptation or through masking of cell 
wall components. This suggests that fungal factors might modulate the epithelial immune response. 
Therefore, in this study a collection of C. albicans mutant strains was analyzed for their ability to 
influence the epithelial cytokine release without affecting host cell damage. As a result, a C. albicans 
strain with a defect in the N-mannan biosynthesis encoded by MNN9 modulated the epithelial 
cytokine response and was further analyzed in vitro and in a mice model of disseminated candidiasis. 
 
 




5 Material and methods 
5.1 Material 
5.1.1 Strains 
All C. albicans and E. coli strains used are listed in Table 1 and Table 2. 
Table 1. C. albicans strains used in this study 
Strain Parental strain Genotype Source, reference 
SC5314 - wild type Gillum et al., 1984 
NGY152 CAI-4 RPS1/rps1::URA3 Sandini et al., 2007 
mnn9Δ/- SC5314 MNN9/mnn9::FRT This study 
mnn9Δ/Δ SC5314 mnn9::FRT/mnn9::FRT This study 
+MNN9 SC5314 mnn9::FRT/mnn9::FRT, 
ADH1/adh1::MNN9-SAT1 
This study 
och1Δ/Δ CAI-4 och1::hisG/och1::hisG, 
RPS1/rps1::CIp10 
Bates et al., 2006 
+OCH1 CAI-4 och1::hisG/och1::hisG, 
RPS1/rps1::CIp10-OCH1 
Bates et al., 2006 
pmr1Δ/Δ CAI-4 pmr1::hisG/pmr1::hisG, 
RPS1/rps1::CIp10 
Bates et al., 2005 
+PMR1 CAI-4 pmr1::hisG/pmr1::hisG, 
RPS1/rps1::CIp10-PMR1 











Hall et al., 2013 
 
Table 2. E. coli strains used in this study 
Strain Parental strain Genotype Source, reference 
DH5α - F- Φ80lacZΔM15 Δ(lacZYA-
argF) U169 recA1 endA1 
hsdR17 (rK-, mK+) phoA 
supE44 λ- thi-1 gyrA96 relA1 
Thermo Fisher 
Scientific 




StellarTM - F-, endA1, supE44, thi-1, 
recA1, relA1, gyrA96, phoA, 
Φ80d lacZΔ M15, Δ (lacZYA - 
argF) U169, Δ (mrr - hsdRMS - 
mcrBC), ΔmcrA, λ- 
Clontech 
ECO_pSFS2A DH5α pSFS2A This study 
ECO_pMNN9-SAT1-
Flipper 
StellarTM pMNN9-SAT1-Flipper This study 
ECO_pSK-ADH1-
CaGFP 
DH5α pSK-ADH1-CaGFP This study 
ECO_pSK-ADH1-
MNN9 
DH5α pSK-ADH1-MNN9 This study 
 
5.1.2 Cell lines 
Human epithelial cell lines used in this study are listed in Table 3. 
Table 3. Cell lines used in this study 
Cell line Origination Cultivation medium Source 
A498 human kidney 
carcinoma, 
proximal tubule 
MEM, 10% FBS DSMZ, ACC 55 
Caco2 human colon 
carcinoma 
DMEM with 4.5 g/L 
Glc, L-Glutamine, 10% 
FBS, 1% of 100x NEAA 
DSMZ, ACC 169 
HepaRG human hepatic 
progenitor cells, 
immortalized 
Williams’ Medium E 
with GlutaMAX , 
HepaRG™ Thaw, Plate 




TR146 human buccal cell 
carcinoma 
DMEM with 4.5 g/L 




5.1.3 Plasmids and oligonucleotides 
Plasmids and oligonucleotides (primers) that were used to generate and verify the MNN9 mutant and 
revertant strains are listed in [Table 4] and [Table 5]. 
Table 4. Plasmids used in this study 




Plasmid Comment Source, reference 
pSFS2A SAT1 flipper cassette Reuß et al., 2004 
pMNN9-SAT1-Flipper MNN9 deletion cassette This study 
pSK-pADH1-CaGFP integrates into ADH1 locus Polke et al., 2017 




Table 5. Used primers in this study 
Primer Sequence (5’ → 3’) 




















AGTAGGAGCTCTTCTTTGGGTACGGTTCAACAC restriction site 
for SacI 
This study 























AGTAGCACGTGCCCACTTGATTTACTCATTAT restriction site 
for PmlI 
This study 
ADHp-fwd GTCATGTGCACGGACAAGC integration in 
ADH1 locus 
forward 
Polke et al., 
2017 





















5.1.4 Media, buffers, kits, enzymes, and chemicals 
Media, buffers, commercial kits, enzymes, and chemicals used in this study are listed in [Table 6], 
[Table 7], [Table 8], [Table 9], and [Table 10]. 
Table 6. Media used in this study 
Medium Composition Application 
Dulbecco’s Modified Eagle 
Medium (DMEM) with high 
glucose 
composed by Gibco (life 
technologies) 
cultivation of TR146 and 
Caco2 
HepaRG Thaw, Plate & 
General Purpose Medium 
Supplement 
composed by Gibco (life 
technologies) 
cultivation of HepaRG 
LB (agar) 1% tryptone, 0.5% yeast 
extract, 1% NaCl, (2% agar) 
cultivation of E. coli 
Minimum Essential Medium 
(MEM) with L-glutamine 
composed by Gibco (life 
technologies) 
cultivation of A498 
NTC YPD agar YPD agar, 200 µg/ml 
Nourseothricin 
mutant generation 
RPMI 1640 composed by Gibco (life 
technologies) 
cultivation of C. albicans 
William’s Medium E (WME) 
with GlutaMAX 
composed by Gibco (life 
technologies) 
cultivation of HepaRG 
YPD (agar) 2% peptone, 1% yeast extract, 
2% D-glucose, (2% agar) 
cultivation of C. albicans 
YPM 2% peptone, 1% yeast extract, 
2% maltose 
mutant generation/ marker 
recycling 
 
Table 7. Buffers used in this study 




Buffer/Solution Composition Application 
10x Tris-EDTA buffer, pH 7.5 100 mM Tris-HCl, 10 mM EDTA mutant generation/ 
transformation 
20x SSC, pH 7.0 3 M NaCl, 0.3 M sodium 
citrate 
Southern blotting 
5x maleic acid buffer, pH 7.5 0.5 M maleic acid, 0.75 M NaCl Southern blotting 
5x sample loading buffer 1.5 M Tris-HCl pH 6.8, 50% 
glycerol, 25% β-
mercaptoethanol, 10% w/v 
SDS, 0.2% Bromphenol Blue 
western blotting 
alkaline phosphatase buffer, 
pH 9.5 
0.1 M Tris-HCl, 0.1 M NaCl Southern blotting 
blocking solution 1% w/v blocking reagent 
(Roche), 0.1 M maleic acid, 
0.15 M NaCl pH 7.5 
Southern blotting 
blotting buffer 200 mM glycine, 25 mM Tris western blotting 
cell detachment solution 0.001% trypsin, 10 mM EDTA, 
PBS 
flow cytometry 
collection gel buffer, pH 6.8 0.5 M Tris western blotting 
denaturing solution 0.5 M NaOH, 1.5 M NaCl Southern blotting 
depurination solution 250 mM HCl Southern blotting 
DNA lysis buffer 1 M sorbitol, 100 mM 
trisodium citrate pH 5.8, 50 
mM EDTA pH 8, 0.06% 
lyticase, 2.5% β- 
mercaptoethanol 
DNA isolation 
DNA proteinase buffer 10 mM Tris-HCl pH 7.5, 50 mM 
EDTA pH 7.5, 0.5% SDS, 0.1% 
proteinase K 1000x stock 
DNA isolation 




Staining Buffer Set 
composed by eBioscience flow cytometry 
Harju buffer 20% Triton X-100, 10% SDS, 5 
M NaCl, 1M Tris-HCl pH 8, 0.5 
M EDTA 
DNA isolation 
high stringency wash buffer 0.1x SSC, 0.1% SDS Southern blotting 
LiAc transformation solution 100 mM lithium acetate, 
10 mM Tris-HCl, 1 mM EDTA,  
mutant generation/ 
transformation 




lithium acetate buffer 1 M lithium acetate mutant generation/ 
transformation 
low stringency wash buffer 2x SSC, 0.1% SDS Southern blotting 
migration buffer 200 mM glycine, 25 mM Tris, 
3.5 mM SDS 
western blotting 
neutralization solution 1 M Tris-HCl pH 7.5, 1.5 M 
NaCl 
Southern blotting 
Odyssey Blocking Buffer TBS-
based 
composed by LI-COR western blotting 
PBS, pH 7.4 140 mM NaCl, 2.7 mM KCl, 10 
mM Na2HPO4,  
1.8 mM KH2PO4 
diverse 
PEG/LiAc solution 80% PEG (50%), 10% lithium 




PEG3650 solution 50% PEG3650 mutant generation/ 
transformation 
RIPA lysis buffer, modified 50 mM Tris-HCL, 150 mM 
NaCl, 1 mM EDTA, 1% Triton X-
100, 0.25 % sodium 
deoxycholate, 0.1% SDS, 1% 
NP-40 
protein isolation 
separation gel buffer, pH 8.8 2 M Tris western blotting 
TBST, pH 7.6 10 mM Tris, 100 mM NaCl, 
0.1% Tween 20 
western blotting 
Tris-HCl, pH 9.0 staining buffer 0.1 M adhesion assay 
washing buffer 1x maleic acid buffer, 0.3% 
Tween 20 (v/v) 
Southern blotting 
 
Table 8. Kits used in this study 
Kit Company Application 
ArC Amine Reactive Compensation Bead Kit Invitrogen flow cytometry 
Cytotoxicity Detection Kit (LDH) Roche damage assay  
Foxp3/Transcription Factor Staining Buffer Set eBioscience flow cytometry 
Human CCL2 (MCP-1) ELISA Ready-SET-Go! eBioscience cytokine measurement 
Human CCL4 (MIP-1β) ELISA Ready-SET-Go! eBioscience cytokine measurement 
Human GM-CSF ELISA Ready-SET-Go! (2nd 
Generation) 
eBioscience cytokine measurement 




Human IL-10 ELISA Ready-SET-Go! eBioscience cytokine measurement 
Human IL-17E ELISA Kit OmniKine cytokine measurement 
Human IL-1α ELISA MAX Deluxe BioLegend cytokine measurement 
Human IL-1β ELISA Ready-SET-Go! (2nd 
Generation) 
eBioscience cytokine measurement 
Human IL-6 ELISA Ready-SET-Go! eBioscience cytokine measurement 
Human IL-8 ELISA Ready-SET-Go! (2nd 
Generation) 
eBioscience cytokine measurement 
Human TNF-α ELISA Ready-SET-Go! eBioscience cytokine measurement 
Human TSLP ELISA Ready-SET-Go! eBioscience cytokine measurement 
innuPrep DOUBLEpure kit Analytik Jena PCR purification 
LEGEND MAX Human IL-33 ELISA BioLegend cytokine measurement 
PCR DIG Probe Synthesis Kit Roche Southern blotting/ probe 
labeling 
Pierce BCA Protein Assay Kit Thermo Fisher 
Scientific 
protein concentration 
SPL Blue Kit NHDyeAgnostics quantitative western 
blotting (SPL) 
SPL Kit Red-IR NHDyeAgnostics quantitative western 
blotting (SPL) 
 
Table 9. Enzymes used in this study 
Enzyme Company Application 
ApaI New England Biolabs mutant generation 
EcoRV New England Biolabs mutant generation 
KpnI New England Biolabs mutant generation 
LongAmp Taq DNA 
polymerase 
New England Biolabs mutant generation 
PciI New England Biolabs mutant generation 
Phusion HF DNA polymerase New England Biolabs mutant generation 
PmlI New England Biolabs mutant generation 
SacI New England Biolabs mutant generation 
SacII New England Biolabs mutant generation 
T4 DNA ligase New England Biolabs mutant generation 
Taq DNA polymerase New England Biolabs mutant generation 
XhoI New England Biolabs mutant generation 
 
Table 10. Chemicals, antibiotics, and ligands used in this study 




Chemicals Company Application 
1 kb DNA Ladder New England Biolabs agarose gel electrophoresis 
6x Loading Dye New England Biolabs agarose gel electrophoresis 
adenosine 5’-triphosphate (ATP) Sigma inflammasome induction 
albumin bovine fraction V (BSA) Serva staining, western blotting 
ammonium persulfate (APS) Serva western blotting/ SDS-PAGE 
anakinra (Kineret) Sobi IL-1R1 blocking 
CDP Star Roche Southern blotting 
chitin from shrimp shells Sigma-Aldrich PRR stimulation 
collagen I from rat tail Gibco (life technologies) coating 
concanavalin A from Canavalia 
ensiformes 
Sigma coating/ fluorescence 
microscopy 
DIG Easy Hyb Roche Southern blotting 
EDTA Sigma-Aldrich protein isolation, western 
blotting 
ethanol 100% Roth DNA isolation 
Fluorescent Brightener 28 
(calcofluor white, CFW) 
Sigma adhesion assay 
furfurman from Malassezia furfur 
cell wall 
InvivoGen PRR stimulation 
glybenclamide InvivoGen inflammasome blocking 
IL-1β Invitrogen ligand 
Immuno Blue reagent NHDyeAgnostics quantitative western 
blotting (SPL) 
iso-propanol (2-propanol) Roth DNA isolation 
lipopolysaccharides   
from E. coli 055:B5 (LPS) 
Sigma inflammasome induction 
L-Lactate Dehydrogenase  Roche LDH standard/ damage 
assay 
LPS-B5 ultrapure LPS from E. coli 
055:B5 
InvivoGen PRR stimulation 
lyticase from Arthrobacter luteus Sigma-Aldrich DNA isolation 
mannan from Saccharomyces 
cerevisiae 
Sigma-Aldrich PRR stimulation 
β- mercaptoethanol Roth western blotting 
Molecular Weight Marker II Roche Southern blotting 
N,N,N’,N’-tetramethylethylen-
diamine (TEMED) 
Serva western blotting/ SDS-PAGE 
Nourseothricin HKI mutant generation 




OneComp eBeads eBioscience flow cytometry 
Pam2CSK4 InvivoGen PRR stimulation 
phenol/chloroform/isoamylalcohol Roth DNA isolation 
phorbol 12-myristate 13-acetate 
(PMA) 
Sigma PRR stimulation 
PhosSTOP EASYpack Roche protein isolation 
poly-D-lysin Chemicon coating 
ProLong Gold Antifading Reagent Invitrogen fluorescence microscopy 
Protease Inhibitor Mix 100x Jena Bioscience protein isolation 
proteinase K Biozym DNA isolation 
Roti-Histofix 4% Roth adhesion, invasion/ fixation 
sheared Salmon Sperm DNA Invitrogen mutant generation 
sodium azide Roth flow cytometry, western 
blotting 
TNF-α Invitrogen ligand 
trehalose-6,6-dibehenate (TDB) InvivoGen PRR stimulation 
Triton-X 100 Sigma invasion assay 
Trypsin-Versene Lonza cell detachment 
Tween 20 Serva invasion assay, western 
blotting 
Western Lightning Plus-ECL PerkinElmer western blotting 
zymosan A from Saccharomyces 
cerevisiae 
Sigma PRR stimulation 
 
5.1.5 Antibodies 
Antibodies used in this study are stated in [Table 11]. 
Table 11. Antibodies used in this study 
Antibody Host/isotype Company Application 
anti-Candida  rabbit Acris Antibodies invasion assay 
anti-digoxygenin anti-DIG-AP Fab 
fragments 
Roche Southern blotting 
anti-human CD206 
Brilliant Violet 421 
mouse, IgG1 BioLegend flow cytometry 
anti-human CD282 
FITC 
mouse, IgG2a BioLegend flow cytometry 
anti-human CD284 
PE-Cyanine7 
mouse, IgG2a eBioscience flow cytometry 






mouse, IgG2b BioLegend flow cytometry 
anti-human CD369 PE mouse, IgG2a BioLegend flow cytometry 
anti-mouse Alexa 
Fluor 488 
goat Invitrogen flow cytometry 









- Invitrogen invasion assay 
anti-rabbit Alexa 
Fluor 647 
- Invitrogen invasion assay 





anti-β-1,3-glucan mouse, IgG Biosupplies flow cytometry/ 
fluorescence 
microscopy 





concanavalin A 647 - Invitrogen flow cytometry/ 
fluorescence 
microscopy 
FVD eFluor506 - eBioscience flow cytometry 
human FcR Blocking 
Reagent 
- Miltenyi Biotec flow cytometry 
IgG1 Brilliant Violet 
421 
mouse Biolegend flow cytometry 
IgG2a FITC mouse BioLegend flow cytometry 
IgG2a PE mouse BioLegend flow cytometry 
IgG2a PE-Cyanine7 mouse eBioscience flow cytometry 
IgG2b APC mouse BioLegend flow cytometry 






Lectin from Triticum 
vulgaris FITC 
- Sigma flow cytometry/ 
fluorescence 
microscopy 































































5.2.1 Escherichia coli storage and cultivation 
E. coli strains were stored at -80°C in 50% (v/v) glycerol. Prior usage, strains were maintained on LB 
agar at 37°C and routinely grown in LB broth at 37°C and 180 rpm. 
5.2.2 Candida albicans storage, cultivation, and growth conditions 
All strains were stored at -80°C in 50% (v/v) glycerol. Prior usage, C. albicans strains were maintained 
on YPD agar at 30°C and cultured in YPD broth at 30°C and 180 rpm. Exponential grown cells were 
used for all experiments and incubated for 3-4 h with a starting inoculum of OD600nm 0.2. Cells were 
collected by centrifugation at 3200 x g, washed three times in phosphate-buffered saline (PBS pH 7.4) 
and counted with a hemocytometer. Aggregating mutant strains were physically separated with a 1 
ml syringe (Ø 0.5 mm, BD Plastipak) by pipetting for at least 10 times prior counting. The cell number 
of C. albicans strains corresponded with the cell number of seeded host cells for a comparable 
multiplicity of infection (MOI). Strains were bi-concentrated in the respective cell culture medium 
without any supplements and ½ volume was added to the wells. For hyphal induction, cells were 
incubated in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum (FBS) at 37°C 




and 5% CO2 for 4 h. Fungal growth was measured in 96-well tissue culture plates in a microplate 
reader (Tecan Infinite 200 Pro) at 30°C for 24 h. To prepare conditioned cell culture medium for 
growth analysis, epithelial cells were grown to 80% confluency and the media replaced with fresh 
medium for 24 h. Then, the supernatant was collected, centrifuged, and filtered through a 0.2 µm 
membrane. 
5.2.3 Cell lines cultivation 
Hepatic epithelial cells (HepaRG) were cultivated in William’s Medium E (WME) with GlutaMAX and 
HepaRG Thaw, Plate & General Purpose Medium Supplement. Renal epithelial cells (A498) were 
cultivated in Minimum Essential Medium (MEM) with L-glutamine supplemented with 10% heat-
inactivated fetal bovine serum (FBS). Oral epithelial cells (TR146) were cultivated in Dulbecco’s 
Modified Eagle Medium (DMEM) with high glucose and supplemented with 10% heat-inactivated FBS. 
All cell line cultivation and infection experiments were performed without antibiotics or antifungal 
agents in a humidified incubator at 37°C, 5% CO2 and 95% humidity. Two days prior the experiment, 
epithelial cells (HepaRG 2x105 cells/ml; A498 and TR146 1x105 cells/ml) were seeded with a final 
volume of 200 µl, 1 ml or 2 ml in 96-, 24- or 6-well tissue culture plates (TPP Techno Plastic Products), 
respectively, to ensure full confluency. At the day of infection, cell culture medium was removed and 
½ volume was added to the wells. 
5.2.4 Isolation of genomic DNA from Candida albicans 
Two different methods were used to isolate genomic DNA from C. albicans: for quantitative assays, a 
freeze and thaw DNA isolation protocol was performed 148. Briefly, 200 µl of Harju buffer was added 
to a pelleted C. albicans culture and incubated for 5 min in -80°C. Afterwards, the frozen sample was 
transferred into a 95°C water bath for 1 min. The last two steps were repeated twice and the 
suspension vortexed. Next, 200 µl phenol/chloroform/isoamylalcohol was added, vortexed for 2 min, 
centrifuged at 20,000 xg for 5 min, and the upper aqueous phase was transferred into 400 µl ice-cold 
100% ethanol. After another centrifugation step, the pellet was washed with 70% ethanol, air-dried, 
and afterwards resuspended in ddH2O. 
Pure and qualitative DNA isolation was used for Southern Blot assays and prepared as the following: 
1 ml DNA lysis buffer was added to a pelleted C. albicans culture and incubated at 37°C for 45 min. 
The suspension was centrifuged at 13,000 xg for 5 min and the pellet resuspended in 800 µl DNA 
proteinase buffer. After incubation at 60°C for 30 min, 800 µl phenol/chloroform/isoamylalcohol was 
added and mixed by vortexing. The suspension was centrifuged again and the upper hydrophilic 
phase was transferred into 700 µl isopropanol, mixed, and centrifuged for 5 min. The pellet was 
washed with 70% ethanol, air-dried, and afterwards resuspended in ddH2O. 
5.2.5 DNA amplification via polymerase chain reaction (PCR) 
To amplify genes, polymerase chain reactions (PCRs) were performed in T-Personal Thermocycler 
(biometra). For sequence verification, Taq DNA polymerase was used. To enable accurate gene 
amplification, proof-reading DNA polymerases LongAmp and Phusion HF were used. For further 
applications, PCR products were purified using the innuPrep DOUBLEpure kit or first separated via 




agarose gel electrophoresis, cut from the gel, and purified using the above mentioned kit. For 
analysis, 6x Loading Dye was mixed with the PCR product and separated in an 1% agarose gel with 1 
kb DNA ladder as a reference. Content of PCR mixes are listed in Table 12 and conditions are listed in 
Table 13. 
Table 12. Reaction setups for different DNA polymerases 
 Taq DNA polymerase LongAmp Taq DNA 
polymerase 
Phusion HF DNA 
polymerase 




Phusion HF Reaction 
Buffer 
10 mM dNTPs 200 µM 300 µM 200 µM 
10 µM primer 
(forward) 
0.2 µM 0.4 µM 0.5 µM 
10 µM primer 
(reverse) 
0.2 µM 0.4 µM 0.5 µM 
Template DNA 50 ng 50 ng 50 ng 
DNA polymerase 0.025 U/µl 0.1 U/µl 0.02 U/µl 
 
Table 13. Thermocycling conditions for different DNA polymerases 
 Taq DNA polymerase LongAmp Taq DNA 
polymerase 
Phusion HF DNA 
polymerase 
 Temperature Time Temperature Time Temperature Time 
Initial denaturation 95°C 30 s 94°C 30 s 98°C 30 s 
Denaturation 
30x 
95°C 30 s 94°C 30 s 98°C 30 s 
Annealing 45-68°C 30 s 45-65°C 60 s 45-72°C 30 s 
Elongation 68°C 1 min / 
kbp 
65°C 50 s / 
kbp 
72°C 30 s / 
kbp 
Final extension 68°C 5 min 65°C 10 min 72°C 10 min 
Hold 8°C ∞ 8°C ∞ 8°C ∞ 
 
5.2.6 Generation of C. albicans MNN9 mutant and revertant strains 
Used plasmids and primers are listed in [Table 4 + Table 5]. All deletion and complementation 
cassettes were verified by PCR, restriction, and sequencing. All C. albicans mutant and revertant 
strains were verified by PCR, sequencing, and Southern blotting. 
To delete MNN9 (ORF19.7383; 1107 bp) the SAT1 flipper method was used in a modified way 149. The 
SAT1 flipper cassette in pSFS2A (isolated from ECO_pSFS2A) was used to construct the MNN9 
deletion cassette: an upstream fragment of MNN9 (position -509 to +26) with the flanking restriction 
sites ApaI and XhoI was amplified from SC5314 genomic DNA with the primer SAT1 mm9-up-for and 




SAT1 mnn9-up-rev. Downstream of MNN9 (position +1092 to +1606) a SacII and SacI flanking 
fragment was amplified with SAT1 mnn9-down-for and Sat1 mnn9-down-rev. Both fragments were 
cloned into pSFS2A resulting in pMNN9-SAT1-Flipper. The original pSFS2A was transformed into E. 
coli DH5α and the recombinant plasmid was transformed into E. coli StellarTM to amplify plasmid DNA. 
The MNN9 deletion cassette was excised from pMNN9-SAT1-Flipper with KpnI and SacI, resulting in 
a 4217 bp linear fragment containing the upstream part of MNN9, FRT site, maltose promotor, a 
flippase, the SAT1 resistance cassette, a second FRT site and the downstream part of MNN9. The 
MNN9 deletion cassette was introduced by chemical transformation into C. albicans SC5314 wild type 
using the modified lithium method [Walther and Wendland, 2003]. Briefly, 1 µg of C. albicans DNA 
was mixed with 100 µg of single-stranded carrier DNA (sheared Salmon Sperm), 100 µl of a C. albicans 
lithium acetate suspension, and 600 µl of PEG/ lithium acetate solution and incubated for 12-16 h at 
30°C under static conditions. To transform the recombinant DNA, heat shock was performed for 15 
min at 44°C. Afterwards, the C. albicans pellet was resuspended in YPD without antibiotics and 
incubated at 30°C for 4 h. To select for positive clones, transformants were plated on YPD agar 
containing 200 µg/ml nourseothricin for 3 days at 30°C. After verification of correct clones via PCR, 
the SAT1 marker from C. albicans mnn9Δ/- was recycled using maltose-containing YPM medium by 
activating the Candida flippase (CaFLP). Then, the second MNN9 allele was removed in the same way, 
resulting in FRT sites in the former MNN9 locus. Gene deletion of C. albicans mnn9Δ/Δ was confirmed 
by the primers mnn9up and mnn9down in PCR, resulting in a 377 bp long fragment. To verify by 
Southern blotting, the probe was generated with the PCR DIG Probe Synthesis Kit using the primers 
probe-mnn9-for and probe-mnn9-rev (231 bp). Genomic DNA was digested with KpnI, separated in 
1% agarose gel by electrophoresis. Depurinated and transferred DNA on a nylon membrane was 
hybridized in Dig Easy Hyb with the single stranded DNA probe at 40°C overnight. Using the CDP Star 
Chemiluminescence System, a homozygous MNN9 mutant was verified by a single band at 2846 bp, 
while the wild type resulted in a band at 3995 bp. 
To restore the wild type phenotype, one allele of the MNN9 gene was integrated into the ADH1 locus 
of C. albicans using a modified pSK-pADH1-CaGFP construct 34. The MNN9 open reading frame was 
amplified with flanking XhoI and the blunt cutter PmlI sites using SAT1-mnn9-comp-for and SAT1-
mnn9-comp-rev from -509 to +1128. CaGFP was cut out from the prior isolated pSK-pADH1-CaGFP 
(originated from ECO_pSK-ADH1-CaGFP) with XhoI and the blunt cutter EcoRV and ligated with the 
MNN9 amplicon resulting in pSK-pADH1-MNN9. The complementation cassette was amplified in 
ECO_pSK-ADH1-MNN9, isolated, cut with KpnI and SacI (5032 bp), and transformed into the MNN9 
homozygous mutant resulting in the strain C. albicans +MNN9. Correct integration into the ADH1 
locus was confirmed by the primers ADHp-fwd (binding genomic DNA) and mnn9down2 (binding in 
the integrated complementation cassette), resulting in a 2632 bp long fragment. To verify by 
Southern blotting the primers probe-mnn9-adh1-for and probe-mnn9-adh1-rev were used to 
generate a 357 bp long probe. Genomic DNA was digested with PciI. The revertant strain was verified 
by two bands at 6775 bp and 3832 bp, whereas the homozygous mutant resulted in one band at 3832 
bp. 




5.2.7 Southern Blotting 
Southern Blotting was performed in order to verify mutant and revertant strains of MNN9. Probes 
were labeled with digoxygenin using the PCR DIG Probe Synthesis Kit. Probes to verify mnn9Δ/Δ were 
generated by using the primers probe-mnn9-for and probe-mnn9-rev resulting in 231 bp. Probes to 
verify the MNN9 revertant strain (mnn9Δ/Δ+MNN9) were generated by using the primers probe-
mnn9-adh1-for and probe-mnn9-adh1-rev resulting in 357 bp. Probe quality was checked via agarose 
gel electrophoresis. Genomic DNA of C. albicans was isolated following section 5.2.4. 12 µg of DNA 
was digested with KpnI to verify MNN9 deletion or the integration of MNN9 into the mnn9Δ/Δ strain. 
Digested genomic DNA was separated in 1% agarose gel at 90 V for 3 h. To estimate band sizes, a DIG-
labeled marker was used (Molecular Weight Marker II). Then, the gel was incubated in depurination 
solution for 20 min, two times in denaturing solution for 10 min, and two times in neutralization 
solution for 10 min at room temperature. The DNA was transferred onto a nylon membrane (Roche) 
using a vacuum blotter at 70-100 mbar for 1.5 h and afterwards crosslinked at 120 mJ/cm² for 1 min 
(Bio-Link, Vilber-Lourmat). The nylon membrane was pre-hybridized with prewarmed DIG Easy Hyb 
at 40°C for 45 min in a hybridization oven (Biometra). Probes were heated to 99°C for 5 min, cooled 
on ice and added to the pre-hybridization solution, following incubation overnight at 40°C under 
rotation. Then, the membrane was washed two times in low stringency buffer for 5 min at room 
temperature, two times in prewarmed high stringency buffer for 15 min at 68°C, two times in maleic 
acid buffer with 0.3% Tween 20 for 5 min at room temperature, and once in maleic acid 
buffer without Tween 20 for 5 min at room temperature. Afterwards, the membrane was blocked for 
30 min at room temperature in 1% blocking solution. The anti-digoxygenin antibody was added 
1:20,000 to the blocking solution and incubated for 1 h at room temperature. Subsequently, the 
membrane was washed two times in 1 x maleic acid buffer with 0.3% Tween 20 for 15 min, and two 
times in 1 x maleic acid buffer without Tween 20 for 15 min. Before detection, the membrane was 
equilibrated in alkaline phosphatase buffer for 5 min. For detection, CDP Star solution was diluted 
1:100 in alkaline phosphatase buffer and the solution evenly distributed on the membrane. After 5 
min of incubation, chemoluminescent signals were detected by a Chemoimager with an exposure 
time of 1-2.5 h. Resulting pictures were inverted and cropped with Adobe Photoshop CS6. 
5.2.8 Epithelial cell damage via LDH release 
To determine epithelial cell damage after 24 h (standard infection assays) or after 2, 4, and 6 h (in 
signaling experiments), lactate dehydrogenase (LDH) activity was measured from cell culture 
supernatant with the Cytotoxicity Detection Kit according to the manufacturer’s protocol. L-LDH from 
rabbit muscle was used to generate the standard curve. 
5.2.9 Cytokine determination 
Infected samples were centrifuged 24 h post infection and the supernatant was analyzed with 
commercially available ELISA kits for IL-1α, IL-1β, IL-10, IL-17E, IL-6, IL-8, IL-33, MIP-1β, MCP-1, TNF-
α, TSLP, and GM-CSF according to the manufacturer’s protocol. 




5.2.10 Large-scale screening of a C. albicans mutant collection 
A collection of 1099 C. albicans transposon mutant strains (Knockout sets from Aaron Mitchell, 
provided by the Fungal Genetics Stock Center) was screened for their ability to damage renal and oral 
epithelial cells and examined the host cell response by quantification of IL-8. Cell lines were cultivated 
as described in section 5.2.3. 5 µl of C. albicans strains from a glycerol stock were incubated in 96-
well tissue culture plates in 95 µl YPD at 30°C and 180 rpm until stationary growth. Then, a dilution 
of 1:20 in fresh YPD was incubated for 16 h at 30°C and 180 rpm. At the day of infection, cell culture 
medium was removed from epithelial cells and 95 µl fresh media without any supplement was added. 
For infection, strains were diluted 1:10 in PBS pH 7.4 and 5 µl was added to the wells. After incubation 
of 24 h in a humidified incubator at 37°C, 5% CO2 and 95% humidity, LDH and IL-8 was measured from 
the supernatant. 
5.2.11 Stimulation of epithelial PRRs with agonists 
To induce a PRR-specific cytokine response, the following agonists were diluted in the respective 
culture media without any supplements and incubated for 24 h: 10 ng/ml Pam2CSK4 to stimulate 
TLR2; 100 µg/ml LPS-B5 ultrapure LPS from E. coli 055:B5 to stimulate TLR4; 100 µg/ml zymosan A 
from S. cerevisiae to stimulate dectin-1; 100 µg/ml furfurman from Malassezia furfur cell wall to 
stimulate dectin-2; and 100 µg/ml trehalose-6,6-dibehenate (TDB) to stimulate mincle/dectin-3. 
Furthermore, 100 µg/ml cell wall extractions of mannan from S. cerevisiae and 100 µg/ml chitin from 
shrimp shell were used to test epithelial activation without PRR-specific stimulation. 
5.2.12 PRR expression in epithelial cells by flow cytometry 
For flow cytometry experiments, all cell lines were grown in 6-well tissue culture plates. Afterwards 
all steps were performed on ice, if not otherwise stated. Noninfected epithelial cell samples were 
washed with PBS and detached with 300 µl 0.001% trypsin and 10 mM EDTA within 15 min. Then, 
600 µl cell culture medium with 10% FBS was added to stop enzymatic reaction and keeping cells 
alive. Infected cell samples containing hyphae were filtered through a 70 µm cell strainer (Corning). 
Cells were counted in PBS and adjusted to 2x105 cells per staining. Cells were stained for viability with 
1:500 FVD eFluor506 according to the manufacturer’s protocol and afterwards washed with FACS 
buffer. To reduce the high autofluorescence background signal that was assessed from all tested 
epithelial cell lines, samples were initially fixed and permeabilized with the Foxp3/Transcription 
Factor Staining Buffer Set according to the manufacturer’s protocol and afterwards stained for the 
targets. Therefore, 2.5 µl of the following antibodies were used to stain 1x106 cells for the respective 
PRR in a multicolor panel: anti-human CD282 FITC (mouse, IgG2a, 1 mg/ml) for TLR2; anti-human 
CD284 PE-Cyanine7 (mouse, IgG2a, 0.2 mg/ml) for TLR4; anti-human CD369 PE (mouse, IgG2a, 0.2 
mg/ml) for dectin-1/CLEC7A; anti-human CD368 APC (mouse, IgG2b, 0.2 mg/ml) for dectin-3/CLEC4D; 
anti-human CD206 Brilliant Violet 421 (mouse, IgG1, 1 mg/ml) for MR. Isotype controls were used in 
the same concentration as for the staining antibodies: mouse IgG2a FITC, mouse IgG2a PE-Cyanine7, 
mouse IgG2a PE, mouse IgG2b APC, mouse IgG1 Brilliant Violet 421. Fc receptors were blocked in the 
staining procedure using human FcR Blocking Reagent with a final dilution of 1:50. Staining and FcR 
blocking reagent were diluted in FACS buffer and incubated with the cell samples in 96-well plate 




with V-bottom for 15-20 min at 4°C. For compensation, each fluorochrome was mixed with OneComp 
eBeads. The live/dead stain was compensated using the ArC Amine Reactive Compensation Bead Kit. 
Samples were analyzed using a FACSVerse flow cytometer and the FACSuite software (BD 
Biosciences). 10,000 events were measured and cells were gated for live (FSC-A/eF506) and single 
cells (FSC-A/FSC-H) prior to analysis of the mean fluorescence intensity (MFI) from the geometric 
mean using FlowJo 10.4.1 (LLJ). 
5.2.13 Yeast PAMP surface exposure by flow cytometry 
Stationary grown C. albicans yeast cells were fixed with Roti-Histofix 4% and adjusted to 5x106 
cells/ml in PBS. Heat-inactivated yeast cells (10 min at 70°C) were used as a control for dead cells. To 
stain for β-1,3-glucan, first cells were blocked with 2% Albumin Bovine Fraction V (BSA) for 10 min at 
37°C. Then, the cells were incubated for 1 h with 2.5 µg/ml anti-β-1,3-glucan (mouse, IgG). The second 
antibody goat anti-mouse Alexa Fluor 488 (1:1000) was incubated for another 1 h. To stain for 
mannan, yeast cells were incubated with concanavalin A Alexa Fluor 647 (1:1000) for 30 min at 37°C. 
To stain for chitin, cells were incubated with Lectin from Triticum vulgaris FITC Conjugate (WGA-FITC, 
1:40) for 1 h at room temperature. Samples were analyzed using a FACSVerse flow cytometer and the 
FACSuite software (BD Biosciences). 10,000 events from stained and unstained samples were 
measured and the mean fluorescence intensity (MFI) was analyzed from single cells (FSC-A/FSC-H) 
using FlowJo 10.4.1 (LLJ). 
5.2.14 Hyphal PAMP surface exposure by fluorescence microscopy 
Glass cover slips were coated with 0.5 mg/ml concanavalin A from Canavalia ensiformes in 24-well 
tissue culture plates to ensure adhesion of strains with weak adhesion properties. Exponential grown 
C. albicans strains were adjusted to 105 cells/ml in RPMI 1640 with 10% FBS and incubated for 4 h 
under humidified conditions in the culture plate. Non-adhered cells were washed with PBS and the 
samples fixed with Roti-Histofix 4%. Next, the samples were incubated with 2% Albumin Bovine 
Fraction V for 10 min at 37°C. For the composite staining the following antibodies were incubate for 
1 h at 37°C: 5 µg/ml anti-β-1,3-glucan (mouse, IgG) for β-1,3-glucan, concanavalin A Alexa Fluor 647 
(1:1000) for mannan, and Lectin from Triticum vulgaris FITC Conjugate (1:200) for chitin. The 
secondary antibody goat anti-mouse PE (1:50) was incubated for 30 min at 37°C. After washing with 
PBS, cover slips were mounted on cover slides with ProLong Gold Antifading Reagent and analyzed 
by fluorescence microscopy (Axio Observer.Z1, Zeiss; Plan-Apochromat 20x/0.8 M27; filter set 38 HE 
for chitin; filter set 43 HE for β-glucan; filter set 50 for mannan). Picture brightness was improved 
with whole image adjustments in the histogram using ZEN 2.3 blue edition (Zeiss). The RPe (red), FITC 
(green), and AF647 (blue) channel were separated with the image export method. Single pictures 
were cropped to 1/3 of the original size without resize and a bar of 20 µm was added. 
5.2.15 Adhesion, invasion, and hyphal length 
Experiments to determine adhesion, invasion, and hyphal length were performed in 24-well tissue 
culture plates on glass cover slides. Because the used cell lines differed in their adherence property 
to glass slides, different preparatory methods were used before seeding: oral epithelial cells were 




seeded on glass cover slides without any additional coating. Hepatic epithelial cells were seeded on 
glass cover slides coated with 0.5 mg/ml concanavalin A from Canavalia ensiformes. Renal epithelial 
cells adhered to glass slides, but medium replacement and washing steps detached these cells 
completely. However, glass slides coated with 0.5 mg/ml Concanavalin A, 10 µg/ml Collagen I from 
rat tail, or 0.1 mg/ml poly-D-lysin did not improve adhesion. Therefore, Clipmax was used that has a 
cyclic olefin polymer (COP) cover slide (TPP Techno Plastic Products), which improved culture 
maintenance and stability during washing steps, but the cell morphology was visibly impaired. 
Clipmax with a polystyrene (PS) cover slide (TPP Techno Plastic Products, commercially not available 
as of March 2019), did not influence cell morphology compared to normal cell culture tissue flasks 
(Cellstar TC, PS, 75 cm², Greiner) and was used for all assays with renal cells. All cell lines were 
cultivated for two days like above mentioned. 
For adhesion assays, exponential grown C. albicans strains were added with a final concentration of 
105 cells/well and incubated for 1 h under humidified conditions. Non-adhered C. albicans cells were 
removed by three washing steps with PBS. Then, samples were fixed with Histofix overnight at 4°C. 
Candida cells were stained with 10 µg/ml Fluorescent Brightener 28 (calcofluor white) in 0.1 M Tris-
HCl (pH 9.0) for 20 min at room temperature. After washing with water, cover slips were mounted on 
cover slides with ProLong Gold Antifading Reagent and analyzed by fluorescence microscopy (Axio 
Observer.Z1, Zeiss). Adhered cells were counted from at least 20 images (EC Plan-Neofluar 10x/0.30 
M27; filter set 49) covering 2/3 of the whole slide resulting in at least 100 cells illustrated in cells per 
high power field. Single cells were counted in cell aggregations which were defined as touching yeast 
cells. 
For invasion assays and hyphal length determination, 0.5x105 cells/well were added for 4 h, washed 
and fixed as above mentioned. To stain outside Candida filaments, samples were incubated with anti-
Candida primary antibody (rabbit, 1:2000) and anti-rabbit Alexa Fluor 488 secondary antibody 
(1:5000) each for 1 h. All washing steps were performed with 0.01% Tween 20. Prior inside/total 
staining of Candida filaments, cells were permeabilized with 0.5% triton-X 100 for 5 min. Then, 
samples were incubated with anti-Candida primary antibody and anti-rabbit Alexa Fluor 647 (1:5000) 
each for 1 h. After washing with water, cover slips were mounted on cover slides with ProLong Gold 
Antifading Reagent and analyzed by fluorescence microscopy (Axio Observer.Z1, Zeiss). At least 120 
filaments were analyzed for invasion (Plan-Apochromat 20x/0.8 M27; filter set 38 HE for outside; 
filter set 50 for inside/total staining). Hyphal length was measured with the line tool and analyzed in 
the measurement tab (ZEN 2.3 blue edition, Zeiss). 
5.2.16 Protein isolation and determination of protein concentration 
Epithelial cells were seeded in 6-well tissue culture plates and grown to confluency for two days.  For 
infection, exponential grown C. albicans was adjusted to a tenfold host cell cell number used for 
seeding (HepaRG 20x105 cells/ml, A498 and TR146 10x105 cells/ml), following published protocols 30. 
Cell culture media were substituted without supplements 16 h prior infection. From mock infected 
controls the media was also exchanged but not from untreated controls (“resting cells”). Cell samples 
were lyzed on ice with a modified RIPA lysis buffer containing phosphatase inhibitors and protease 




inhibitors. The suspension was incubated on ice for 30 min, centrifuged at 15,000 xg for 15 min and 
the supernatant was used to determine the protein concentration with the Pierce BCA Protein Assay 
Kit according to the manufacturer’s protocol. 
5.2.17 Target expression analysis via western blotting 
Expression of c-Fos and NF-κB was determined by standard western blotting. Denaturized 10-15 µg 
protein (to analyze c-Fos) or 5 µg protein (to analyze NF-κB) in sample loading buffer were separated 
in 12.5% acrylamide gels via SDS polyacrylamide gel electrophoresis (SDS-PAGE) using the Biometra 
Eco-Mini system (Analytik Jena) and Mini-PROTEAN Tetra Vertical Electrophoresis Cell (Bio-Rad). 
Then, proteins were transferred on a PVDF membrane (Amersham Hybond 0.45 PVDF) and blocked 
afterwards with 5% BSA for 1 h. Primary antibodies were diluted in 5% BSA with 0.02% sodium azide 
1:1000 for c-Fos (monoclonal, rabbit IgG), 1:1000 phospho-NF-κB p65 (monoclonal, rabbit IgG), 
1:1000 NF-κB p65 (monoclonal, mouse IgG2b) and incubated overnight at 4°C. Washing steps were 
performed in TBS with 0.1% Tween 20. The secondary antibodies anti-rabbit IgG HRP-linked and anti-
mouse IgG HRP-linked were incubated for 1 h at room temperature. Blots were incubated with the 
chemiluminescent Western Lightning Plus-ECL for 1 min and emitting light was detected for 1-5 min 
with a ChemoImager (Chemi-Smart 5000, Vilber-Lourmat). Pictures were inverted and cropped for 
the target with Adobe Photoshop CS6. 
5.2.18 Quantitative target expression via Smart Protein Layer (SPL) western 
blotting 
The MAPK signaling targets MKP1, ERK1/2, and JNK were quantified with the Smart Protein Layer 
technology from NH DyeAgnostics 150. For MKP1 and JNK, two blots were prepared for the 
phosphorylated and the total target protein. For ERK1/2, phosphorylated and total target protein was 
analyzed on the same blot, using mouse and rabbit antibodies to distinguish between both states. 10 
to 15 µg protein was used from 2 and 4 h samples and 8 µg protein from 6 h samples. The protein 
samples were labeled with the SPL Blue Kit or SPL Kit Red-IR according to the manufacturer’s protocol 
with target-specific adjustments: the bi-fluorescent Calibrators A and B (Cal A and B) for experiment-
to-experiment comparisons and antibody signal comparisons were not mixed due to different 
brightness levels. Cal A was diluted with 2 µl of a water-loading buffer mixture instead of Cal B. Cal B 
was diluted to obtain a similar signal intensity like the targets, which was determined in test blots 
before. Because mouse and rabbit secondary antibodies were used to detect target signals, Cal B was 
also used with these two isotypes. Cal B rabbit was diluted 1:5 for ERK1/2, and 1:20 for JNK and MKP1 
targets. Cal B mouse was diluted 1:2 for ERK1/2 and MKP1, and 1:4 for JNK targets. Smartalyzer basic 
S (SMA S, 25 kDa) was used as loading control and added to each protein sample. To label the total 
protein amount, 2 µl (not 1 µl, to enhance labeling efficiency) Smart Label Reagent working solution 
was added to the protein samples and mixed with the reaction and loading mix (RL-mix). Denaturized 
Cal A, Cal B, and protein samples were separated in 12.5% acrylamide gels via SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) using the Biometra Eco-Mini system (Analytik Jena) and Mini-PROTEAN 
Tetra Vertical Electrophoresis Cell (Bio-Rad). The running front was cut out from the gel before image 
acquisition was performed by Octoplus QPLEX (NHDyeAGNOSTICS). Using the SPL Blue Kit, the gel 




fluorescence was documented in blue (GDye 100) for gel total protein (GTO), and red (GDye 300) for 
SMA (gel loading: GLO); or with the SPL Kit Red-IR in red for GTO and infrared (GDye 400) for SMA. 
Then proteins were transferred on a low-fluorescent PVDF membrane (low-fluorescent PVDF Blotting 
Kit, NHDyeAGNOSTICS) via sandwich wet transfer blotting in an electrical field. The membrane was 
blocked for 1 h at room temperature with 5% BSA or Odyssey Blocking Buffer in a TBS-based buffer 
system. The following primary antibodies were separately incubated in 5% BSA or Odyssey Blocking 
Buffer (TBS) at 4°C overnight: 1:1000 phospho-DUSP1/MKP1 (monoclonal, rabbit IgG); 1:100 MKP1 
(monoclonal, mouse IgG3); 1:1000 phospho-p44/42 MAPK ERK1/2 XP (monoclonal, rabbit IgG); 
1:1000 p44/42 MAPK ERK1/2 (monoclonal, mouse IgG1); 1:1000 phospho-SAPK/JNK (monoclonal, 
rabbit IgG); 1:100 JNK (monoclonal, mouse IgG1). Washing steps were performed in TBS with 0.1% 
Tween 20. Secondary antibodies Smart Infrared Fluorescent anti-rabbit IgG or Smart Red Fluorescent 
anti-mouse IgG (both goat) were diluted 1:1000 and incubated for 1 h at room temperature. 
Using the SPL Blue Kit, signal intensity from the blot was documented using blue fluorescence channel 
for blot total protein (BTO), infrared fluorescence for blot target protein 1 (BTA 1, e.g. phosphorylated 
target, bound through anti-rabbit secondary antibody), or red fluorescence for blot target protein 2 
(BTA 2, total target protein on a second blot, bound through anti-mouse secondary antibody). When 
the total target protein was determined on the same blot (BTA 1 and BTA 2), the (mouse) secondary 
antibody was incubated for another 1 h at room temperature. Then BTO 2 (blue) was detected a 
second time, and the blot target protein 2 (BTA 2, total target protein) was detected in red.  
Using the SPL Kit Red-IR, the signal intensity from the blot was documented using red fluorescence 
channel for blot total protein (BTO), infrared fluorescence for blot target protein 1 (BTA 1, e.g. 
phosphorylated target, bound through anti-rabbit secondary antibody), or blue fluorescence for blot 
target protein 2 (BTA 2, total target protein on a second blot, bound through anti-mouse secondary 
antibody). When the total target protein was determined on the same blot (BTA 1 and BTA 2), the 
(mouse) secondary antibody was incubated for another 1 h at room temperature. Then BTO 2 (red) 
was detected a second time, and the blot target protein 2 (BTA 2, total target protein) was detected 
in blue. 
To increase the signal-to-noise ratio from low-abundance target proteins the HRP-coupled antibodies 
anti-rabbit IgG HRP-linked or anti-mouse IgG HRP-linked were used as secondary antibodies for 
incubation instead of the above described fluorescence-conjugated antibodies. Then, blots were 
analyzed in the blue fluorescent channel to determine BTO. Afterwards the Immuno Blue reagent 
was added to the blot resulting in a stable blue fluorescent signal. 
To avoid overexposed pictures, the fluorescence signal was detected manually just below the 
saturation threshold. GTO, GLO, BTO1/2 and BTA1/2 pictures were analyzed using LabImage 1D 
Version 3.4.5 (Kapelan Bio-Imaging) following the SPL-LabImage Software Package manual from 
NHDyeAGNOSTICS. Lanes and bands on the blot were detected with the automatic lane/band search 
or manually. For background noise reduction the rolling ball with 45 pixels were applied. SMA and Cal 
A bands were detected from GLO and transferred on GTO. Then SMA and Cal A bands were detected 




from BTO. Cal B and target bands were detected on BTA. A template was adjusted to assign lanes and 
band names for an automatic normalization with the Project Comparator. For normalization, three 
steps were (automatically) performed: normalization for equal loading of protein samples based on 
SMA basic in GLO. Next, the labeling efficiency of the samples was normalized by analyzing the band 
volume of SMA in GTO. Then, target signals were normalized to total protein in BTO. With this three 
normalization steps the target protein signals were determined in BTA. SPL normalized target signal 
intensities were compared to the mock infection control. Because mock infected samples did not 
differ in their phosphorylation status at all tested time points, the 2 h time point was used as 
reference for all other time points from infected samples. 
5.2.19 Inflammasome activation, blocking of the IL-1 receptor, and blocking of the 
NLRP3 inflammasome 
To induce the inflammasome, epithelial cells were primed with 1 µg/ml LPS for 3 h, washed with PBS, 
and added 5 mM ATP for 24 h as a second stimulus. Cytokine release of IL-1α and IL-1β was analyzed 
from the supernatant as described above. 10 µg/ml anakinra (Kineret) was used to block the IL-1 
receptor IL-1R1. 25 µg/ml glybenclamide was used as a potassium channel inhibitor to block the 
maturation of caspase-1 resulting in the blocking of the NLRP3 inflammasome. Both blocking reagents 
were directly added during infection. 
5.2.20 Murine systemic candidiasis model 
Female BALB/c mice (eight weeks old, Charles River Germany) were housed without antibiotics. For 
infection, cryostored C. albicans strains were plated on YPD agar, restreaked on plate, and incubated 
in YPD overnight at 30°C. Cells were washed in ice-cold PBS and afterwards physically separated with 
a syringe (Ø 0.5 mm, BD Plastipak) by pipetting for at least 10 times prior counting. Mice were infected 
with 2.5x104 cells/g body weight via lateral tail vein. The health status was monitored twice a day by 
examination of temperature, weight and behavior. Survival was monitored over 21 days and mice 
showing severe illness were euthanized. To analyze fungal burden, organs were separated, weighed, 
homogenized in PBS, plated in serial dilutions on YPD agar, and incubated for two days at 30°C. For 
histological analysis, cross-section organ slices were fixed, embedded in wax, and stained with 
periodic acid-Schiff (PAS). Samples were analyzed using Axio Observer.Z1 (Zeiss) in the channel TL 
Brightfield with a color camera with a 40x magnification (EC Plan-Neofluar 40x/0.75 M27) for single 
pictures. Whole organ images were generated by taking pictures with the tile method (EC Plan-
Neofluar 10x/0.30 M27) and afterwards stitched into one image using the stitch method (ZEN 2.3 
blue edition, Zeiss). 
5.2.21 Ethic statement 
Animal experiments were performed in accordance with the German animal protection law and were 
approved by the Federal State authority (Thüringer Landesamt für Verbraucherschutz) ethics 
committee (beratende Komission nach §15 Abs. 1 TierSchG; permit no. 03–023/16). The animals were 
cared in accordance with the European Convention for the Protection of Vertebrate Animals Used for 
Experimental and Other Scientific Purposes. 




5.2.22 Statistical analysis 
All graphs display the mean of biological replicates with standard deviation. Statistical analyses were 
performed using GraphPad Prism 7.04. Differences between groups were performed using one-way 
ANOVA with Tukey’s multiple comparisons test. Comparisons to one control group were performed 







6.1 Epithelial damage and cytokine release in response to C. albicans 
infection 
Epithelial cells lining mucosal surfaces represent the first line of defense against invading pathogens. 
The epithelium not only serves as a physical barrier but also senses host cell injury and induces an 
innate immune response 36. Production and secretion of inflammatory cytokines by mucosal epithelial 
cells activate resident immune cells and further contribute to the recruitment of additional immune 
cells that could clear infections 151,152. Previous studies of the epithelial immune response mainly 
focused on the oral and vaginal epithelium that is commonly colonized by C. albicans. These surfaces 
can be affected by superficial fungal infections that trigger the release of IL-6, IL-8, IL-1α/β, GM-CSF, 
and TNF-α depending on cell lysis 113,151–153. Mucosal epithelial cells from the gastro-intestinal tract 
and lung also respond to C. albicans infection 154–156. However, the fungus also interacts with other 
types of epithelial cells that form the parenchyma of internal organs, e.g. from the kidney 157. In 
systemic candidiasis of mice, the cytokine profile from the kidney does not correlate with the low 
number of residential immune cells or delayed kinetics of recruited immune cells 145,147,158. Therefore 
epithelial cells might contribute to this organ-specific response leading to the immunopathology of 
C. albicans infection. 
6.1.1 C. albicans causes less damage to oral epithelial cells in comparison to 
hepatic and renal epithelial cells 
Secretion of inflammatory cytokines from oral and vaginal epithelial cells is damage-dependent 
20,58,151. To compare the damaging capabilities of C. albicans on different cell lines, 2x104 of oral 
(TR146) and renal (A498) cells and the double amount of hepatic (HepaRG) cells were seeded in a 96-
well tissue culture plate and grown to full confluency within two days. For infection, C. albicans wild 
type SC5314 cells were added with the same cell number of seeded host cells to enable a comparable 
multiplicity of infection (MOI) by less than one. After 24 h released lactate dehydrogenase (LDH) was 
determined in the supernatant and unveiled differences between these cell lines (Fig. 5). Nearly all 
hepatic and renal cells were damaged based on comparison to total cell lysis induced by Triton. In 







6.1.2 The cytokine response towards C. albicans infection differs between 
epithelial cells 
Next, inflammatory cytokines were quantified from the supernatant by enzyme-linked 
immunosorbent assay (ELISA) and revealed further cell type-specific differences: even though all cell 
lines secreted interleukin (IL)-6 and IL-8 in response to C. albicans infection, hepatic epithelial cells 
secreted significantly lower amounts of IL-6 and slightly less IL-8 compared to renal and oral epithelial 
cells (Fig. 6A). Nonetheless, IL-6 and IL-8 secretion by infected hepatic cells was significantly increased 
compared to mock-infected control (Fig. 6B). TNF-α was also released by all cell lines upon infection 
with the highest release observed for hepatic cells (Fig. 7A). IL-1α and IL-1β were exclusively secreted 
by oral epithelial cells (Fig. 7B). While the release of IL-1α is associated with damage, IL-1β release 
requires active production and secretion mediated by the inflammasome 159. To test whether an 
inflammasome-associated cytokine response could be induced in hepatic and renal epithelial cells, 
LPS was used for initial priming followed by stimulation with ATP 136,137,160, but this did not result in 
any IL-1 release in hepatic and renal epithelial cell lines (data not shown). 
Fig. 5. Epithelial cell damage induced by C. albicans SC5314. 
Confluent hepatic (HepaRG), renal (A498), and oral (TR146) epithelial cell lines were mock-infected 
(control) or infected with C. albicans SC5314 for 24 h. To induce total cell lysis, triton was added 5 min 
prior the end of the experiment. Lactate dehydrogenase (LDH) was quantified from supernatants. Data 





Furthermore, TSLP was released in small amounts by infected hepatocytes (Fig. 7C), and IL-33 by 
infected hepatic and oral cells (Fig. 7D). The inflammatory cytokine MCP-1, that generally is involved 
in the early acute-phase response during systemic infection, was induced by C. albicans only in 
infected renal cells, whereas infection reduced the amount secreted by hepatic and oral cells (Fig. 
7E). GM-CSF, MIP-1β, IL-17E (IL-25), and the anti-inflammatory cytokine IL-10 were not detectable in 
the supernatant of any cell line (data not shown). 
Thus, C. albicans infection caused damage in epithelial cells from different organs, with susceptibility 
differing between different cell lines, and induced an innate immune response by a core secretion of 
the inflammatory cytokines IL-6 and IL-8, and additionally by the secretion of cell line-specific 
cytokines. 
Fig. 6. Cell line-dependent IL-6 and IL-8 release induced by C. albicans SC5314. 
Confluent hepatic (HepaRG), renal (A498), and oral (TR146) cell cultures were mock-infected (control) or 
infected with C. albicans SC5314 for 24 h. (A) IL-6 and IL-8 were quantified from supernatants by ELISA. 
(B) Relative increase of IL-6 or IL-8 release compared to the mock-infected control. Data represent mean 
values +/- SD from at least six independent experiments. &, below detection limit. Statistics: One-way 






6.2 Pattern recognition receptors (PRRs) expressed by different epithelial 
cells 
Pathogen-induced cytokine secretion depends on stimulation of pattern recognition receptors (PRRs) 
101,161. Additionally, induction of cytokine release by oral and vaginal epithelial cells requires cell 
damage 21,58,151. The cell lines analyzed in this study were substantially damaged by C. albicans 
infection and therefore insufficient damage could be excluded as an explanation for the differences 
in cytokine production. This suggested that epithelial-specific expression of PRRs could lead to the 
differences in cytokine induction in response to C. albicans. 
6.2.1 Hepatic, renal, and oral epithelial cells express a similar repertoire of PRRs 
To investigate the two main classes of PRRs recognizing C. albicans cell wall components 101, 
expression of toll-like receptors (TLRs) and C-type lectin receptors (CLRs) was analyzed by flow 
cytometry. Preliminary experiments revealed a strong autofluorescence from all analyzed cell lines 
that could be reduced by permeabilization with saponin resulting in the staining of total PRR 
expression rather than surface expression. The mean fluorescence intensity (MFI) was analyzed from 
the geometric mean of all samples. To determine nonspecific binding of the fluorescence antibodies, 
isotype controls were used, and the resulting MFI were comparable in most cases with the unstained 
samples (data not shown). However, since not all available isotype controls perfectly matched all 
specific antibodies, and it is widely accepted to refrain from using isotype controls in quantitative 
Fig. 7. Epithelial-specific cytokine response induced by C. albicans SC5314. 
Confluent hepatic (HepaRG), renal (A498), and oral (TR146) cell cultures were mock-infected (control) or 
infected with C. albicans SC5314 for 24 h. TNF-α (A), IL-1α and IL-1β (B), TSLP (C), IL-33 (D), and MCP-1 (E) 
were quantified from supernatants by ELISA. Data represent mean values +/- SD from at least three 





assays 162, the MFI of stained samples were compared to the unstained one. The relative MFI was 
increased in all cell lines for TLR2, TLR4, dectin-1, dectin-3, and at low levels for MR (Fig. 8), indicating 
expression of these PRRs. From all tested PRRs, the MFI for TLR4 showed the strongest intensity in all 
three cell lines. Compared to renal and oral cells, hepatic cells displayed the highest relative increase 
in the MFI of TLR2, TLR4, dectin-1, dectin-3; suggesting a stronger PRR expression in this cell line. 
Some studies have been demonstrated that infection changes PRR gene transcription 163,164. 
Therefore, PRR expression was analyzed in cell lines stimulated with both IL-1β and TNF-α, zymosan 
A, or co-incubated with live C. albicans for 7 h. This stimulation, however, did not influence the 
relative MFI compared to unstimulated controls (Fig. 9). 
Fig. 8. Similar repertoire of pattern recognition receptors (PRRs) expressed by different epithelial cells. 
PRR expression from unstimulated hepatic, renal, and oral epithelial cells grown for two days. Cells were 
removed (0.001 % trypsin + 10 mM EDTA) and stained for dead cells (eF506),  and the PRRs TLR2, TLR4, 
dectin-1, dectin-3, and MR. 10.000 events were gated for live cells (FSC-A/eF506), then for single cells 
(FSC-A/FSC-H). The mean fluorescence intensity (MFI) was analyzed from the geometric mean and the 
relative MFI was compared to unstained samples depicted from at least four independent experiments 
+/- SD. Dotted baseline: MFI=1. Statistics: One-way ANOVA with post-hoc Tukey’s multiple comparisons 






6.2.2 Epithelial cells differ in the responsiveness to PRR ligands 
Host cells express TLRs and CLRs to recognize microbial pathogens rapidly. While results in this study 
demonstrate that composition and expression levels of PRRs do not explain the epithelial-specific 
cytokine response, cells can differ in the responsiveness of PRR-induced signaling cascades. To test 
this hypothesis, PRRs were stimulated with specific ligands (Pam2CSK4 for TLR2, purified LPS-B5 for 
TLR4, zymosan A for dectin-1, furfurman for dectin-2, trehalose-6,6-dibehenate (TDB) for dectin-3 
stimulation) and IL-8 release was quantified after 24 h of incubation. From all tested cell lines, hepatic 
epithelial cells were most responsive to all tested PRR ligands and induced a strong IL-8 release after 
Fig. 9. PRR expression is unaltered after cytokine stimulation or infection with C. albicans. 
Confluent hepatic, renal, and oral cells were either unstimulated, stimulated with both IL-1β and TNF-α, 
or zymosan A for 24 h (A) or infected with C. albicans for 7 h (B). Cells were removed (0.001 % trypsin + 
10 mM EDTA) and stained for dead cells (eF506),  and the PRRs TLR2, TLR4, dectin-1, dectin-3, and MR. 
10.000 events were gated for live cells (FSC-A/eF506), then for single cells (FSC-A/FSC-H). The mean 
fluorescence intensity (MFI) was analyzed from the geometric mean and the relative MFI was compared 





stimulating TLR2, TLR4, dectin-1, and dectin-2 (Fig. 10) without causing damage (data not shown). 
Stimulation of PRRs of oral cells did not induce IL-8 secretion compared to the unstimulated control, 
confirming that the oral cytokine response additionally requires damage-dependent signaling 58. 
Renal epithelial cells were solely responsive to TLR2 and dectin-3 stimulation. 
It has been shown that myeloid cells, e.g. monocytes and macrophages, respond to fungal cell wall 
components, specifically mannan 107, β-glucan 165,166, and chitin 94. In contrast to innate immune cells, 
cell wall extractions from S. cerevisiae mannan or chitin from shrimp shell did not induce IL-8 
secretion by oral epithelial cells without damage 151,163. Likewise, mannan did not induce a response 
by the other cell lines either. Hepatic and renal cells secreted small amounts of IL-8 when stimulated 
with chitin. 
In summary, while oral epithelial cells require damage to induce a PRR-mediated cytokine response, 
renal and in particular hepatic cells respond to a variety of ligands by inducing IL-8 secretion. This 
strong hepatic cytokine secretion could contribute to the overall cytokine response during infection 
independent from the damage caused by the pathogen. 
6.3 Fungal factors modulating the epithelial cytokine response 
Disseminated candidiasis in mice results in an early and strong cytokine expression in the kidney that 
could not originate from the low number of residential immune cells 145,147. It is, therefore, possible 
that epithelial cells contribute to the innate immune response by secreting inflammatory cytokines. 
C. albicans can bypass the innate immune system by metabolic adaptation or through masking 
immunoactive cell wall components 167. One of the few known fungal factors that directly modulate 
Fig. 10. Responsiveness of TLRs and CLRs differ between epithelial cells. 
IL-8 released in the supernatant from hepatic, renal, and oral epithelial cells stimulated with PRR ligands 
for 24 h. The following PRRs were stimulated: TLR2 (Pam2CSK4), TLR4 (LPS-B5), dectin-1 (zymosan A), 
dectin-2 (furfurman), and dectin-3 (trehalose-6,6-dibehenate, TDB); mannan and chitin. Data represent 






the epithelial cytokine response are secreted aspartyl proteinases (SAPs) 21. Part of this study was to 
discover new fungal factors that have an immunomodulatory effect on epithelial cells. 
6.3.1 Identification of C. albicans factors that influence epithelial cytokine 
secretion 
To screen for fungal factors that can modulate the epithelial cytokine response, a commercially 
available collection of 1099 C. albicans transposon mutant strains 168 was analyzed for their ability to 
damage renal and oral cells and to induce IL-8 secretion. The capability to induce IL-8 secretion 
appeared to correlate with host cell damage, and most of the strains showed a similar damage and 
cytokine response as it was observed for parental strains (Fig. 11, a z score of zero represents the 
parental strain). While strains with a defect in filamentation (8%) or a growth defect (3%) were 
excluded from further analysis, as this would reduce damage of host cells, strains that did not 
correlate in damage and cytokine release, or induced an epithelial-specific immune response, were 
selected for further analysis. Therefore, the relative cell damage and relative IL-8 secretion were 
calculated based on the respective parental strain. Mutant strains with a standard deviation of less 
than 1 in damage were considered to induce unaltered cell damage. For the IL-8 release, strains with 
a standard deviation of more than 1.5 were considered to induce a stronger or weaker cytokine 
response. In total, 68 putative candidates were selected for a triplicate repetition that confirmed the 
phenotype for one-third of these strains. 11 transposon mutants with the strongest alteration in IL-8 
induction were selected for further analysis including gene mutations in CHD1, RIC1, SUV3, RFG1, 
Fig. 11. Damage-dependent IL-6 and IL-8 release of renal and oral epithelial cells. 
Confluent renal and oral cell cultures were infected with a collection of 1099 C. albicans transposon 
strains. After 24 h, lactate dehydrogenase (LDH), IL-6, and IL-8 were quantified from supernatants. The z 
score indicates the distribution of standard deviations from the mean represent by the parental strain and 






PHO23, MCM1, SCH9, SPT20, ORF19.764, BAS1, and MNN9 (Table 14). To further analyze the 
epithelial-specific immune response; intestinal, hepatic, renal, and, oral epithelial cells were infected 
with each of the eleven mutant strains. Some strains displayed increased damage to intestinal and 
oral cells but not hepatic and renal cells (Fig. S1A). A strong increase of IL-8 secretion was observed 
in oral cells in response to mutant strains such as suv3Δ/Δ or mnn9Δ/Δ (Fig. S1B). None of the 
analyzed mutant strains induced a stronger IL-8 release of renal cells compared to the respective 
parental strain. 
Table 14. Possible C. albicans factors that modulate the epithelial-specific cytokine response 
Open Reading 
Frame (ORF) 
gene (putative) function 
orf19.2823 RFG1 transcriptional repressor 
orf19.7383 MNN9 protein mannosylation 
orf19.6036 RIC1 unknown 
orf19.829 SCH9 protein kinase 
orf19.4519 SUV3 RNA helicase 
orf19.3809 BAS1 transcription factor, purine biosynthesis 
orf19.422 SPT20 transcriptional co-activator 
orf19.1759 PHO23 unknown 
orf19.7025 MCM1 transcription factor 
orf19.3035 CHD1 unknown 
orf19.764 - unknown 
6.3.2 A defect in the mannosyltransferase II partly encoded by MNN9 modulates 
the epithelial-specific cytokine response 
The large-scale host response screening revealed 11 possible fungal factors that could modulate an 
epithelial cytokine response. To verify the phenotype of these transposon mutants, homozygous gene 
deletion mutants were generated with the SAT1 flipper method in the marker-free genetic 
background of the C. albicans wild type SC5314 149. Successfully created homozygous gene deletion 
strains of RIC1, SUV3, and MNN9 were used for infection of hepatic, renal, and oral epithelial cells 
(data not shown). From all tested candidates, deletion of MNN9 showed the strongest phenotype: 
while hepatic and oral cell damage was similar compared to the parental strain (Fig. 12A), mnn9Δ/Δ 
induced significantly more IL-6 and IL-8 secretion by hepatic cells and elevated levels of IL-6 and 
significantly more IL-8 by oral cells (Fig. 12B+C). In renal cells, however, a reduced damage also 
resulted in a decreased cytokine response. The elevated cytokine response was reversed in the 






6.4 Influence of cell wall mannosylation on the epithelial immune 
response 
Deletion of MNN9 caused an increased hepatic and oral epithelial cytokine response while the 
damage potential did not differ. MNN9 encodes for a subunit of the mannan polymerase complex II 
and is involved in the N-linked outer-chain mannan and protein glycosylation by adding α-1,6-
mannose to the N-mannan backbone 169. As a consequence, MNN9 activity influences the elongation 
of the α-1,6-mannose backbone that is essential for further additions of α-1,2-mannose sidechains 
and phosphomannan capping 69. During infection, fungal cell wall components are crucial for the 
stimulation of host cells by their interaction with PRRs 35. Mannosylation has a significant impact on 
the accessibility of cell wall components and thus subsequent host cell responses 163,170,171. To gain 
further insight into the role of N-mannosylation on epithelial cell type-specific immune responses, C. 
albicans mutants were selected that display gradually different degrees of the mannosylation status. 
This included an OCH1 mutant with an absent α-1,6-mannose backbone 68; a PMR1 mutant with 
Fig. 12. Deletion of C. albicans MNN9 modulates the epithelial-specific cytokine response. 
Confluent hepatic, renal, and oral epithelial cell lines infected with C. albicans mnn9∆/∆ for 24 h under 
standard culture conditions. Cell culture supernatant was assessed for lactate dehydrogenase (LDH, A) 
measuring epithelial cell damage, or the amount of IL-6 (B) and IL-8 by ELISA (C). Data represent mean 
values +/- SD from at least four independent experiments (three for the heterozygous mutant). Statistics: 





shorter N- and O-mannosylation chains 172; and a strain lacking all α-1,2-mannose side chains due to 
the deletion of the whole MNN2 gene family (the mmn2Δsextuple mutant 75). 
6.4.1 The degree of mannosylation affects epithelial damage and cytokine 
response 
Oral epithelial cells differentially respond to N- and O-mannosylation defects of the C. albicans cell 
wall that particularly depends on fungal pathogenicity rather than the glycosylation status 98. To test 
the influence of an altered mannosylation status on mucosal and parenchymal epithelial cells, the 
supernatant from infected hepatic, renal, and oral epithelial cells was analyzed for released LDH, IL-
6, and IL-8; and compared the results with the respective parental strain. A deletion in OCH1 
abolished hyphal formation and did neither induce host cell damage nor any cytokine response by 
Fig. 13. The cell wall mannosylation status affects epithelial cell damage and cytokine secretion. 
Confluent hepatic, renal, and oral epithelial cell lines infected with different C. albicans mannosylation 
mutants for 24 h under standard culture conditions. Cell culture supernatant was assessed for lactate 
dehydrogenase (LDH, A) measuring epithelial cell damage, or the amount of IL-6 (B) or IL-8 by ELISA (C). 
Data represent mean values +/- SD from at least three independent experiments. Statistics: One-way 
ANOVA with post-hoc Dunnett’s multiple comparisons test; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, 





the tested epithelial cells (Fig. 13). Deletion of PMR1 decreased the damage observed in hepatic and 
renal cells and induced less IL-6 and IL-8 secretion, particularly in renal cells. Oral cell damage was 
also reduced by the pmr1Δ/Δ; however, secreted levels of IL-6 and IL-8 were comparable with the 
parental strain. The MNN2 sextuple mutant displayed an increase in cytokine response by hepatic 
and oral cells similar to the mnn9Δ/Δ. However, while hepatic and oral damage induced by the 
mnn9Δ/Δ was comparable to the parental strain, the MNN2 sextuple mutant caused more damage 
to these cell lines. Another cell type-specific difference was observed for renal epithelial cells: the 
mnn9Δ/Δ caused slightly less renal cell damage and consequently induced less cytokine release. 
However, damage induced by the MNN2 sextuple mutant was comparable to the parental strain, but 
the cytokine response was moderately increased. Other strains from the transposon mutant 
collection that have an unaltered α-1,6-mannose N-mannan backbone, but subtle alterations in side 
chains of α-1,2-mannose or α-1,3-mannose (mutation in either MNN14 or MNN22 75,78) did not alter 
the epithelial cytokine response (Fig. S2). 
6.4.2 Induction of the epithelial inflammasome-associated IL-1 secretion 
In this study, it could be shown that only oral epithelial cells but not hepatic or renal epithelial cells, 
secreted IL-1 in response to C. albicans infection. While IL-1α is usually released upon cell damage, 
IL-1β is actively secreted depending on caspase-1 159. Activation of myeloid caspase-1 requires TLR2 
and dectin-1 signaling as a first stimulus and formation of the NLRP3 inflammasome as a second 
stimulus. Both, IL-1α and IL-1β bind to the same IL-1 receptor (IL-1R1), induce their own production 






6.4.2.1 The release of oral IL-1 is damage-dependent and correlates with IL-6 and 
IL-8 
 
Fig. 14. Blocking of the IL-1 receptor (IL-1R1) in oral epithelial cells decreases the release of 
inflammatory cytokines independent from the mannosylation status. 
Oral cells were infected with different mannosylation mutants and corresponding parental strains for 24 
h. (A) Cell culture supernatants from at least four (two for och1Δ/Δ and +OCH1) independent experiments 
were used to determine the release of IL-1α and IL-1β. The values obtained for the parental strains were 
set to 100%. (B) Effect of IL-1R1 blocking with 10 µg/ml anakinra on damage determined by LDH release 
into supernatants and the relative secretion of IL-8, IL- 1α, and IL-1β. The values obtained for unblocked 
cells were set to 100%. Data are depicted as mean +/- SD from at least three independent experiments. 
Statistics: One-way ANOVA with post-hoc Dunnett’s multiple comparisons test; *, P ≤ 0.05; **, P ≤ 0.01; 





Elevated IL-6 and IL-8 release triggered by the mnn9Δ/Δ and MNN2 sextuple mutant strains raised 
the question whether the release of IL-1 is also affected by the glycosylation status. Like IL-6 and IL-8 
secretion, the release of oral IL-1α has been shown to be dependent on C. albicans-mediated damage 
174. This could also be shown for the damage-deficient och1Δ/Δ, which did not induce IL-1 secretion 
(Fig. 14A, for damage see Fig. 13A). Although the damage capacity of the pmr1Δ/Δ was reduced (Fig. 
13A), secreted amounts of IL-1α and IL-1β were similar to the parental strain (Fig. 14A) and 
corresponded with secreted IL-6 and IL-8 levels (Fig. 13B+C). While the MNN2 sextuple mutant caused 
enhanced damage and induced a twofold IL-1 secretion, the mnn9Δ/Δ strain induced a similar IL-1 
release compared to the MNN2 sextuple mutant but damaged oral cells to the same extent as the 
parental strain. 
6.4.2.2 Defects in mannosylation do not affect IL-1R1-dependent IL-1 release 
Binding of IL-1 to the IL-1R1 induces the production and secretion of inflammatory cytokines 105,175. 
Therefore, the increased amount of IL-1 release by oral epithelial cells in response to infection with 
the mnn9Δ/Δ and MNN2 sextuple mutants could potentiate the cytokine response, as it was observed 
for IL-8, via binding of IL-1R1 (Fig. 13C). To examine the role of IL-1R1 signaling in the overall cytokine 
response, the receptor was blocked during infection with the antagonist Anakinra (also known as 
Kineret), and the release of LDH, IL-1α, IL-1β, and IL-8 was determined from the supernatant. 
Compared to the infected and unblocked sample, the addition of Anakinra reduced the relative IL-8 
secretion independent from the glycosylation status (Fig. 14B). Likewise, IL-1α was reduced, even 
though blocking the IL-1R1 did not influence cell damage. Secretion of IL-1β was reduced by half when 
oral cells were blocked with Anakinra, showing that IL-1β production partially depends on IL-1 
receptor signaling. 
6.4.2.3 Oral IL-1 secretion is independent of the NLRP3 inflammasome 
Processing and secretion of IL-1β by caspase-1 requires induction of the inflammasome 139. The 
canonical NLRP3 inflammasome is by far the best characterized inflammasome that is also expressed 
in many epithelial cells 134. To test whether the oral cytokine response is dependent on the NLRP3 
inflammasome, the potassium channel inhibitor glybenclamide was used to inhibit maturation of 
caspase-1. Inhibition did not reduce IL-1β secretion after infection with any of the tested strains and 
did also not affect IL-8 and IL-1α secretion (Fig. 15). Thus, the NLRP3-independent release of oral IL-






6.4.3 Strain-dependent adhesion and invasion properties do not correlate with 
the induced cytokine response 
Adhesion to host cells is a prerequisite for C. albicans to colonize mucosal surfaces and is also required 
for PRR-mediated signaling to induce an epithelial immune response 176. Therefore, increased 
adhesion by the mnn9Δ/Δ and MNN2 sextuple mutant might contribute to the higher cytokine 
response observed by oral and hepatic cells. To test this hypothesis, epithelial cells were seeded on 
glass cover slides and infected with C. albicans strains for 1 h and subsequently stained to enable 
counting of fungal cells. While adhesion to oral cells was unaltered of the mnn9Δ/Δ and MNN2 
sextuple mutant, both strains adhered less to hepatic cells than the parental strain (Fig. 16A). It thus 
appears unlikely that the enhanced hepatic cytokine production can be attributed to C. albicans 
adhesion properties. The MNN2 sextuple mutant adhered better on renal epithelial cells, which might 
contribute to the observed inflammatory cytokine release in comparison to mnn9Δ/Δ. Yeast cells of 
both mannosylation mutant strains clustered in large cell aggregates on the cell layer of all cell lines 
(Fig. 16B). This cell aggregation has been described before and could be explained by cell wall 
separation defects or a change in the overall net charge of the cells 68,97,171,172,177. 
Fig. 15. Inhibition of caspase-1 maturation does not influence the inflammatory cytokine release. 
The maturation of caspase-1 was inhibited with 25 µg/ml glybenclamide during C. albicans infection and 
the cell culture supernatant from three independent experiments was assessed for LDH, or IL-8, IL-1α, and 





Hyphal growth is considered to be crucial for fungal invasion and critical for virulence 118. The ability 
to invade epithelial cells was analyzed after 4 h of infection by differential fluorescent staining that 
discriminates non-invasive from invasive C. albicans hyphae. The staining revealed that the mnn9Δ/Δ 
and MNN2 sextuple mutant grew less invasively into hepatic, renal, and oral cells (Fig. 17A). Hyphal 
formation has been previously demonstrated for the mnn9Δ/Δ and MNN2 sextuple mutant under 
hypha-inducing conditions 75,97. However, after 4 h of infection of epithelial cells, both strains 
developed shorter hyphae than the wild type (Fig. 17B). In contrast, hyphal length was not impaired 
of the MNN2 sextuple mutant when incubated without epithelial cells on glass cover slides (Fig. S3). 
Fig. 16. Strain-specific adhesion on hepatic, renal and oral epithelial cells. 
To determine adhesion, C. albicans strains were co-incubated for 1 h with confluent epithelial cells and 
afterwards stained for counting fungal cells. (A) Relative adhesion of C. albicans mnn9Δ/Δ, +MNN9, and 
MNN2 sextuple mutant compared to the parental strain. Statistics: One-way ANOVA with post-hoc 
Dunnett’s multiple comparisons test; **, P ≤ 0.01. (B) Number of yeast cells forming one aggregate, 
defined as touching yeast cells. Statistics: One-way ANOVA with post-hoc Tukey’s multiple comparisons 
test; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001; ns = not significant. (A+B) Data represent 
mean values +/- SD from at least three independent experiments. SC5314 is the parental strain from the 






6.4.4 Normal yeast cell growth of glycosylation mutant strains 
The mnn9Δ/Δ and MNN2 sextuple mutant induced a stronger hepatic and oral cytokine response that 
could not be explained by alterations in adhesion, invasion, or hyphal length. To test whether any of 
the observed phenotype is influenced by alterations in propagation, mutant strains and the 
respective wild types were analyzed in growth at 30°C in 96-well tissue culture plates. Yeast growth 
of both strains was not fundamental impaired in standard YPD medium at 30°C (Fig. 18). Since all 
infection experiments were performed in the respective cell culture medium, C. albicans yeast growth 
was analyzed in pure (data not shown) or conditioned DMEM (incubated with oral cells), conditioned 
MEM (incubated with renal cells), and conditioned WME (incubated with hepatic cells) without 
supplements at 30°C. While the MNN2 sextuple mutant displayed a slight growth delay in conditioned 
DMEM, mnn9Δ/Δ grew slightly slower in conditioned WME (Fig. 18). Both mutant strains showed no 
alterations in growth when incubated with conditioned MEM. Thus, even though the mnn9Δ/Δ and 
MNN2 sextuple mutant displayed aggregating phenotypes and a reduced hyphal growth on epithelial 
cells, yeast cell growth was not impaired. 
Fig. 17. Strain-specific invasion in hepatic, renal and oral epithelial cells. 
C. albicans strains were co-incubated for 4 h on confluent epithelial cells. To analyze invasion properties, 
outside hyphal structures, invaded hyphae, and total hyphae were discriminated by differential 
fluorescent staining and the relative amount of invasion calculated (A); or the total hyphae length was 
measured (B). SC5314 is the parental strain from the MNN9 mutant and +MNN9; NGY152 is the parental 
strain from the MNN2 sextuple mutant. (A+B) Data represent mean values +/- SD from at least three 
independent experiments. Statistics: One-way ANOVA with post-hoc Tukey’s multiple comparisons test; 






6.4.5 Mannosylation mutant strains expose more β-1,3-glucan and chitin on their 
surface 
The C. albicans cell wall consists of 35-40% mannoproteins, 60% β-glucans, and 1-2% chitin 59. This 
ratio can change by deletion of genes involved in mannosylation that elevates glucan and chitin levels 
due to compensatory regulation 178. However, changes in cell wall composition also affect the 
expression of epitopes that are in direct contact to host cells. Thus, an altered pathogen-associated 
molecular pattern (PAMP) exposure might contribute to differential recognition resulting in the 
observed changes in the host cells’ cytokine response. 
Therefore, exposure of the cell wall PAMPs mannan, β-1,3-glucan, and chitin was analyzed from yeast 
cells by flow cytometry (Fig. S4). The relative MFI compared to the parental strain revealed a 
decreased mannan exposure on the MNN2 sextuple and pmr1Δ/Δ but not on mnn9Δ/Δ or och1Δ/Δ 
(Fig. 19). In contrast, β-1,3-glucan exposure was increased in all glycosylation mutants. As a positive 
control for β-1,3-glucan exposure, heat-inactivated yeast cells of SC5314 were used that expose more 
β-1,3-glucan evoked by structural distortion of the cell wall than intact wild type cells 178. The inner 
skeletal layer consists of chitin and is usually exposed only at bud scars 84. However, all mannosylation 
mutants showed a strong increase in chitin exposure. Although heat-inactivated SC5314 cells used as 
a positive control for exposed chitin displayed slightly more chitin exposure compared to intact wild 
type cells, this control exposed less chitin compared to the tested mannosylation mutant strains. This 
suggests a compensatory de novo chitin synthesis in these glycosylation mutant. 
Fig. 18. Deletion of MNN9 or MNN2 does not impair growth in different media. 
C. albicans strains were grown for 24 h in YPD, conditioned DMEM, MEM, or WME in 96-well tissue culture 






C. albicans filamentous growth is associated with cell wall remodeling that alters PAMP exposure 35. 
As a consequence, different PAMP exposure on filaments from glycosylation mutants might 
contribute to an altered recognition and thus cytokine response. To test this hypothesis, C. albicans 
strains were incubated for 4 h under filamenting conditions (RPMI 1640 with 10% FBS, 37°C, 5% CO2) 
and differentially stained for exposed mannan, β-1,3-glucan, and chitin. As flow cytometry is not 
suitable to analyze C. albicans hyphae, fluorescence microscopy was used to analyze PAMP exposure. 
As already observed for yeast cells analyzed by flow cytometry, yeast cells from the SC5314 wild type 
and MNN9 revertant strain exposed less β-1,3-glucan (red) and chitin (green) compared to the 
mnn9Δ/Δ and MNN2 sextuple mutant (Fig. 20). Both mutant strains displayed different cell wall 
component exposure patterns also on filaments: while β-1,3-glucan exposure was observed along all 
filaments of mnn9Δ/Δ and MNN2 sextuple mutant, the staining appeared only on hyphal tips, 
secondary and branching hyphae of the wild type and revertant strain. Wild type and revertant strain 
exposed chitin at bud scars and the first hyphal septa. On filaments of the mnn9Δ/Δ, chitin septa were 
not specifically visible between hyphal cells; instead, a pattern of laterally dense chitin rings was 
visible. 
Fig. 19. Exposure of cell wall mannan, β-1,3-glucan, and chitin on C. albicans glycosylation mutant 
strains. 
Exposure of mannan, β-1,3-glucan, and chitin from different glycosylation mutants measured by the mean 
fluorescence intensity (MFI) relative to their respective parental strains. Data is depicted as mean +/- SD 
from at least three independent experiments. h.i., heat-inactivated. Statistics: One-way ANOVA with post-






In contrast, the MNN2 sextuple mutant exposed chitin on all hyphal septa. Only the mnn9Δ/Δ strain 
did not expose chitin at hyphal septa (Fig. 21), suggesting a defect in hyphal separation. However, 
total staining of chitin with the diffusible molecule calcofluor white displayed normal separated 
hyphal cells (Fig. S5). 
Fig. 20. Exposure of hyphal cell wall PAMPs on C. albicans SC5314, mnn9Δ/Δ, +MNN9, and MNN2 
sextuple mutant determined by fluorescence microscopy. 
C. albicans hyphae were induced by 4 h incubation in RPMI 1640 with 10% FBS, 37°C, 5 % CO2. 
Representative images of at least two independent experiments. The white arrow indicates yeast cells. 






6.5 Analysis of signaling pathways involved in the epithelial immune 
response 
C. albicans infected epithelial cells responded with a distinct secretion pattern of inflammatory 
cytokines. Even though the process of receptor-mediated recognition of C. albicans is still unknown 
37, different epithelial cells express a similar repertoire of PRRs but respond differently to ligands. This 
Fig. 21. Glycosylation mutants differ in their filamentous chitin exposure. 
C. albicans strains were grown for 4 h under hyphae-inducing conditions and stained for exposed mannan 
(blue), β-1,3-glucan (red), and chitin (green), displayed as an overlay. Representative images of at least 
two independent experiments. Arrows indicate the first chitin separation ring. Note: The mnn9 mutant 





suggests a cell type-specific induction of signaling cascades downstream of PRRs. Previous studies 
identified the activation of mitogen-activated protein kinase (MAPK) signaling including MKP1 and c-
Fos in response to C. albicans-mediated cell damage 151. However, while the activation of these 
pathways is considered to be crucial for cytokine release by oral and vaginal cells 151,152, epithelial cells 
from different origins might differentially activate signaling pathways. 
6.5.1 Activation of C. albicans-induced mitogen-activated protein kinase (MAPK) 
signaling 
MKP1 phosphorylation in oral and vaginal cells has been demonstrated to appear earliest by 2 h upon 
C. albicans infection 151,152. This activation was induced by a dose-dependent fungal burden and 
required a tenfold higher MOI in vaginal cells. To enable MKP1 activation in hepatic, renal, and oral 
cell lines, the increased MOI was also used in this study. 
6.5.1.1 Damage-dependent activation of MKP1 phosphorylation is cell line-
specific 
MKP1 phosphorylation was analyzed after 2 h, 4 h, and 6 h of C. albicans infection by quantitative 
western blotting using the fluorescence-based Smart Protein Layer (SPL) method 150. This method 
allowed normalization to the total protein amount instead of a single housekeeping protein. Mock-
infected cell lines did not display changes in MKP phosphorylation during incubation determined by 
standard western blotting (data not shown), or in case of the oral cell line by SPL (Fig. 22A). 
Infection of hepatic cells with C. albicans SC5314 decreased SPL normalized intensities of both MKP1 
and p-MKP1 (Fig. 22B). In contrast, p-MKP1 increased by 4 h post-infection in renal and oral cells, 
while intensities for MKP1 remained stable in these cell lines. The ratio of p-MKP1/MKP1 compared 
to the mock-infected control revealed cell type-specific kinetics: while p-MKP1 immediately 
decreased after infection of hepatic cells, it increased by 4 h in renal and oral cells and slightly 






Cytokine release by oral epithelial cells is induced by the activation of signaling cascades that requires 
sensing by PRRs and cell lysis 20,58,151. Released LDH, however, revealed cell line-specific differences in 
the early induction of cell damage: LDH was detected as early as 4 h after infection of hepatic cells 
but was very low or absent of renal and oral cells (Fig. 22D). Cell damage further increased of hepatic 
and renal cells by 6 h, but oral damage was almost absent. It thus appears unlikely that the reduced 
MKP1 phosphorylation in hepatic cells is due to the absence of damage. 
6.5.1.2 Activation of c-Fos is independent of C. albicans infection 
Activation of MKP1 and c-Fos might not be directly linked but are crucial for a hypha-associated 
induction of the cytokine response in oral and vaginal cells 151,152. In the discrimination of commensal 
and pathogenic lifestyle of C. albicans, activation of c-Fos results in the production of cytokines 151. 
Induction of c-Fos was analyzed by standard western blotting and revealed C. albicans-independent 
activation by 2 h (Fig. 23). Mock-infected hepatic and renal cells already induced c-Fos and the signal 
intensity did not increase in response to infection. Oral cells did not respond to mock or C. albicans 
infection after 2 h (Fig. 23) or after 4 h (Fig. S.7). 
 
Fig. 22. Cell type-specific activation of MKP1 during C. albicans infection. 
(A) Oral cells were either untreated or mock-infected for 2, 4, and 6 h and p-MKP1 and MKP1 analyzed by 
quantitative western blotting using the Smart Protein Layer technology (SPL, from NHDyeAGNOSTICS). (B) 
Confluent hepatic, renal, and oral cells were either mock-infected or infected with C. albicans for 2, 4, and 
6 h and analyzed by quantitative western blotting . Relative amount of MKP1 and p-MKP1 normalized to 
the whole protein amount over time. (C) p-MKP1/MKP1 ratio after infection with C. albicans over time. 
(D) Lactate dehydrogenase (LDH) released into the supernatant during the infection period. Data from A 
displays one experiment analyzed by SPL and was verified in two independent experiments by standard 







6.5.1.3 A defect in MNN9 induces a delayed but strong MAPK signaling in oral 
epithelial cells 
The mnn9Δ/Δ strain induced an elevated oral cytokine response and caused normal cell damage. The 
strong exposure of β-1,3-glucan and chitin on both yeast and hyphae suggests differences in the 
activation of MAPK signaling. Since activation of MKP1 is crucial in the regulation of cytokine 
induction 151, C. albicans-induced phosphorylation of MKP1 might alter the response to infection with 
mnn9Δ/Δ. Activated MKP1 is stabilized by ERK1/2 179, and in case of increased or prolonged activation 
of ERK1/2, phosphorylation of MKP1 might also increase. Furthermore, ERK1/2 is supposed to 
regulate the cytokine response mediated by p38 and JNK signaling. JNK is dephosphorylated by MKP1 
in order to control the epithelial immune response and it has been demonstrated that the activation 
of both proteins displayed opposing kinetics 151. 
To examine the different activation of MKP1, ERK1/2, and JNK signaling pathways in oral cells, 
phosphorylation levels were quantified by SPL western blot. MKP1 phosphorylation was delayed 
when infected with mnn9Δ/Δ but reached wild type levels by 6 h (Fig. 24A). Early induction of 
phosphorylated ERK1/2 by mnn9Δ/Δ appeared similar compared to wild type infection, but further 
increased in mnn9Δ/Δ infected samples that support the hypothesis of a stronger and prolonged 
MKP1 activation by ERK1/2 (Fig. 24B). The mnn9Δ/Δ strain did not induce JNK signaling at early time 
points, but phosphorylation increased during infection with similar kinetics of wild type-infected cells 
(Fig. 24C). This increase in JNK phosphorylation, however, is in contrast to the previously 
demonstrated opposing phosphorylation of MKP1 and JNK 151. 
Fig. 23. C. albicans-independent induction of c-Fos. 
c-Fos expression in untreated, mock-infected, and with C. albicans SC5314 infected epithelial cells after 2 





Early host cell damage induced by mnn9Δ/Δ could contribute to a progressive activation of MAPK 
signaling pathways and an increased oral cytokine release. However, damage was not detectable 
after 6 h of infection with the mnn9Δ/Δ strain, suggesting MAPK activation before damage (Fig. 24D). 
6.5.2 Activation of C. albicans-induced NF-κB signaling 
The activation of NF-κB is independent of C. albicans morphology and only partially involved in the 
epithelial cytokine response 151. However, it has been shown that blocking of the NF-κB pathway 
significantly reduces the amount of secreted cytokines, even though it does not reduce MKP1 and c-
Fos activation 151. The authors suggest that cytokine production might be partly independent of the 
MAPK-induced activation of c-Fos. Furthermore, the C. albicans cell wall moieties mannan, β-glucan, 
and chitin activate NF-κB 151, which might also contribute to the elevated cytokine response induced 
by the mnn9Δ/Δ. However, phosphorylated NF-κB analyzed by standard western blotting was not 
induced by C. albicans infection by 2 h (Fig. 25), or at later time points (data not shown). Likewise the 
induction of c-Fos, phosphorylated NF-κB was already observed in mock-infected samples. 
 
Fig. 24. Delayed but increased phosphorylation of ERK1/2, MKP1 and JNK after infection with the MNN9 
mutant. 
MKP1, ERK1/2, and JNK phosphorylation in oral cells was quantified similar to Fig. 22 by using the Smart 
Protein Layer technology (SPL, from NHDyeAGNOSTICS). Relative p-MKP1/MKP1 (A), p-ERK/ERK (B), and 
p-JNK/JNK (C) ratios after infection with C. albicans SC5314 or MNN9 mutant normalized to mock-infected 
controls. (D) Lactate dehydrogenase (LDH) released in the supernatant of oral cells after incubation with 





6.6 MNN9 is required for full virulence in vivo 
Alterations in the mannosylation status of the cell wall have been shown to often reduce virulence in 
disseminated candidiasis in mice. Structural defects in mannosylation caused by minor alteration in 
the α-1,2-mannose side-chains in a MNN14 mutant strain 78; the loss of N-mannan sidechains in a 
MNN2 sextuple mutant 75; partly loss of O- and N-mannan in a PMR1 mutant strain 172; a shorter α-
1,6-mannose backbone in a MNN10 mutant strain 72; or the lack of the whole N-mannosyl residue in 
the och1Δ/Δ 68,107 improved mice survival upon infection with these strains. So far, the influence of 
alterations in the mannosylation status caused by the mnn9Δ/Δ mutant was not tested in vivo before. 
The structural similarity of the mnn9Δ/Δ mutant with the mnn10Δ/Δ mutant suggested a similar 
virulence in systemic candidiasis in mice.  
To test the virulence of C. albicans mnn9Δ/Δ in vivo, BALB/c mice were intravenously infected with 
5x105 cells of the SC5314 wild type, mnn9Δ/Δ, or revertant strain. Infection with the wild type 
resulted in a median survival of 4 days (Fig. 26A). In contrast, infection with the mnn9Δ/Δ strain 
resulted in 100% survival of the group after 21 days post infection. The revertant strain containing a 
single MNN9 copy caused a median survival of 6.5 days. 
  
Fig. 25. C. albicans-independent activation of NF-κB. 
Expression and activation of NF-κB in mock-infected and with C. albicans SC5314 infected epithelial cells 





Organ fungal burden was analyzed by colony forming unit (CFU) plating from all mice and revealed a 
high fungal burden in the kidney (Fig. 26B), spleen, liver, and brain (Fig. S6) of mice infected with the 
wild type strain. The fungal load in the kidney was reduced when infected with the revertant strain, 
suggesting a partial clearing of the fungus, but this was not sufficient for mice to survive the infection. 
Mice that were infected with mnn9Δ/Δ and euthanized 21 days post infection showed less fungal 
burden in the kidney, but the infection was not fully cleared. Instead, histological periodic acid-Schiff 
staining (PAS) showed that in these kidneys granulomas filled with filamentous mnn9Δ/Δ were 
formed (Fig. 26D and Fig. 27). In contrast, wild type filaments were located in the cortex and renal 
papilla accompanied by a strong inflammatory immune cell infiltration (Fig. 26C). 
Mice infected with the MNN9 mutant displayed a low summarized clinical score that includes 
estimation of mice behavior, fur, examination of weight, and temperature (Fig. S8). While a clinical 
score of zero implies a perfect health status, the score observed for mice infected with the MNN9 
mutant could hint to a delayed pathogenesis that could also impair survival. 
  
Fig. 26. MNN9 is required for full virulence of C. albicans in disseminated candidiasis in mice. 
BALB/c mice were infected intravenously with 5x105 C. albicans strains and survival was assessed for 21 
days (A). Depicted is one representative from two independent experiments with 8 mice per group. 
Median survival infected with the WT: 4 days; with the mutant: 21 days; with the revertant: 6.5 days. 
Statistics: log-rank (Mantel-Cox) WT to mutant ****; WT to revertant ****; mutant to revertant: ***. 
Fungal burden in the kidney at the day by death determined as colony forming units per gram organ (B). 
Colonized kidney section after 4 days of infection with the WT (C) or after 21 days with the mnn9Δ/Δ (D). 
Arrows indicate C. albicans filaments. Pictures are representative PAS staining from kidney sections. For 





In summary, a defect in the mannosyltransferase II part encoded by MNN9 resulted in 100% survival 
of intravenously infected mice but the mutant strain was not fully cleared and mice suffered from 
relatively high fungal loads in the kidney. 
 
Fig. 27. Kidney granulomas caused by the MNN9 mutant strain. 
Longitudinal section of a healthy kidney (left) and a kidney filled with granulomas from the same mouse 






Innate immunity plays an important role in early C. albicans recognition and clearance of infection 
180,181. Epithelial cells lining mucosal surfaces represent not only passive barriers but rather non-
professional immune cells that induce an innate immune response by secreting chemokines, 
cytokines, and antimicrobial peptides 182. Previous studies focused on the immune response from oral 
and vaginal epithelial cells, which are representative for mucosal surfaces 30,31,98,183. They are 
constantly in contact with pathogens and can be affected by superficial candidiasis. When C. albicans 
reaches the bloodstream, infection of internal organs also leads to the interaction of the fungus with 
other types of epithelial cells that form the parenchyma of internal organs. These epithelial cells are 
normally not populated by microbes and do not interact with pathogens under non-infected 
conditions. How these types of epithelial cells recognize and respond to C. albicans is largely 
unknown. 
The aim of this study was to compare the cytokine response of different types of epithelial cells 
towards C. albicans infection. Furthermore, this work identified the glycosylation status of the C. 
albicans cell wall as a factor that modulates the epithelial cytokine response in a cell type-dependent 
manner. 
7.1 Mucosal and parenchymal epithelial cells produce cytokines that could 
contribute to the innate immune response 
All epithelial cell lines investigated in this study secreted IL-6 and IL-8 when challenged with C. 
albicans. This inflammatory cytokine response, however, quantitatively differed between cell types, 
with more cytokines produced by oral epithelial cells compared to hepatic and renal cells (this study), 
or vaginal cells 31,184. The epithelial damage potential also differed between cell lines and revealed 
that oral cells were more robust to C. albicans-induced damage in vitro. It is therefore possible that 
more host cells were intact after oral cell infection which were capable of producing more cytokines 
under the same conditions compared to renal and hepatic cells. Given that the prevalence of 
commensal C. albicans colonization of oral and vaginal surfaces is very high 2, epithelial cells that form 
mucosal barriers must have evolutionary evolved mechanisms to adapt to fungal invasion and 
damage. In contrast, epithelial cells of internal organs are only confronted with microbes, including 
C. albicans, during infection. IL-8 release from epithelial cells in vitro was only observed after infection 
with C. albicans, confirming that IL-8 requires de novo synthesis 20. Secreted IL-8 is the most important 
chemoattractant for neutrophils and macrophages, the principal effector cells to clear C. albicans 
infection 121. However, it is still unknown, how much epithelial cells contribute to the overall IL-8 
production that is necessary to recruit neutrophils for host defense during systemic candidiasis. 
IL-6 is considered to be double-edged, operating as pro- and anti-inflammatory cytokine 185. Infected 
hepatic cells released low amounts of IL-6, but relatively high amounts compared to the mock-
infected control. However, significant amounts of IL-6 is considered to be secreted from neutrophils, 





release compared to other cell lines, it has been shown that IL-6  impairs hepatic detoxification by 
downregulating drug transporter mRNA expression from the hepatic epithelial cell line HepaRG 187. 
Moreover, intestinal epithelial cells did also not secrete IL-6 in response to C. albicans infection 
(unpublished data; and Daig and coworkers (2000) 188) revealing a tissue-dependent IL-6 secretion. 
Bloodstream infections induce a core unit of acute-phase response cytokines including TNF-α, IL-1β, 
IL-8, and MCP-1 189 that can cause a cytokine storm resulting in multiorgan failure and lethality 190. 
While this cytokine response is usually induced by immune cells, epithelial cells might also contribute 
to the overwhelming host response. Due to their barrier function against invading pathogens, 
epithelial cells at mucosal surfaces are most likely stronger involved in the initial immune response 
than parenchymal epithelial cells that are usually sterile. Interestingly, this study demonstrates that 
parenchymal epithelial cells not only respond in the secretion of IL-8 in response to C. albicans 
infection but also released cytokines that were absent or have been found at lower levels from oral 
epithelial cells, e.g. MCP-1, IL-33, TSLP, and TNF-α. MCP-1 was already secreted from mock-infected 
epithelial cells and the secretion increased after infection only by renal cells. Epithelial MCP-1 
secretion is considered to facilitate epithelial-mesenchymal transition 191 and to control bacterial 
infections 192, but the specific role in fungal immunity is unknown. Steele and Fidel (2002) suggested 
that constitutively expressed cytokines by epithelial cells could retain homeostasis of the innate 
immunity 184. 
7.2 Colonized epithelial cells express inflammasomes that enable early 
recognition of pathogen-induced damage by the secretion of IL-1β 
Inflammasomes are multicomponent protein complexes that sense inflammation and are involved in 
wound healing by the of activation caspase-1 to induce IL-1β and IL-18 production, cleavage, and 
secretion 105. Production and secretion of IL-1β from macrophages requires first the transcriptional 
regulation of expression induced by PAMP recognition through TLRs, IL-1R, and TNFR, and next the 
induction of the inflammasome resulting in caspase-1 activation 139. The NLRP3 inflammasome 
consists of the NOD-like receptor NLRP3, and its expression is primed through activated NF-κB 135, the 
latter which is activated after PRR stimulation and also induces the production of IL-6 and IL-8 139. 
Then, the assembly of the NLRP3 inflammasome is activated by a large variety of signals related to 
stress and damage, e.g. by TLR ligands and cytokines 138, pore-forming toxins 139,140,193, or NF-κB 
activators such as UV light and reactive oxygen species 139.  
Expression of different inflammasomes has been demonstrated in myeloid compartments and also 
epithelial cells, e.g. intestinal and oral epithelial cells 133. The ability to release IL-1β in response to 
PAMPs, however, differs between tissues and is not solely dependent on inflammasome expression. 
For example, while several groups observed expression of the NLRP3 inflammasome in human 
primary bronchial epithelial cells 133,134, stimulation of these cells with Pseudomonas aeruginosa 
PAO1, LPS, and ATP did not induce IL-1β 194. 
Mucosal cells from the upper respiratory tract and the intestine are typical ports of microbial entry 





These so-called lymphoreticular organs show a high IL-1 and a low IL-6 activity 195. In this study, IL-1β 
was only secreted by oral epithelial cells in response to C. albicans infection. Although few amounts 
of IL-1β were secreted into the supernatant, its pro-inflammatory effect is already active at low 
concentrations and therefore might have clinical relevance 196. However, the main source of IL-1β 
secretion originates from the myeloid compartment such as monocytes, macrophages, and dendritic 
cells 196. 
Hepatic and renal epithelial cells did not release IL-1β upon C. albicans infection or stimulation in 
vitro. This has also been shown for the renal cell line A498 after infection with different E. coli strains 
197,198, suggesting that parenchymal epithelial cells do not contain inflammasomes to detect the 
presence of pathogens. Another explanation for the absence of inflammasomes in hepatic epithelial 
cells could be the negative influence of IL-1 on hepatic detoxification. IL-1β can induce its own 
expression via an autocrine or paracrine positive feedback loop 199, and additionally can induce the 
secretion of epithelial IL-6 and IL-8 173,200,201. IL-1β and IL-6 have been shown to impair detoxification 
by downregulating transporter mRNA expression from the hepatic cell line HepaRG 187. Therefore, 
hepatic epithelial cells limit uncontrolled inflammation by preventing the release of IL-1β.  
Oral epithelial cells contain high constitutive levels of IL-1α which is released during cell death 138 that 
suggests a correlation between released LDH and IL-1α. Surprisingly, the MNN9 mutant damaged oral 
cells like the wild type but induced a stronger IL-1α release presumably by de novo synthesis. A similar 
increase of released IL-1α was also observed when infected with the MNN2 sextuple mutant, even 
though the strain damaged oral cells slightly better that could have caused the observed cytokine 
release. 
In macrophages C. albicans filaments activate caspase-1 through the NLRP3 inflammasome and 
induce IL-1β secretion 131,136. NLRP3 is also expressed in many epithelial cells including oral epithelial 
cells 134. This led to the hypothesis that NLRP3 in oral epithelial cells triggers caspase-1 activation and 
therefore IL-1 production. However, using glybenclamide to block the potassium efflux that inhibits 
NLRP3 inflammasome activation did not impair any cytokine response. Besides the NLRP3 
inflammasome, activation of the NLRC4 inflammasome has been shown to induce IL-1β secretion 
from murine buccal mucosa 132. It, therefore, appears that different inflammasomes could activate 
specific caspases, e.g. caspase-1. However, a noncanonical inflammasome that can activate caspase-
11 could also play a role in the oral IL-1 activation 138. 
7.2.1 Aggregating C. albicans strains could elevate the host response induced by 
PAMPs and DAMPs 
Both the MNN9 mutant and MNN2 sextuple mutant strains grew in aggregates and formed an uneven 
meshwork of filaments causing fungal hotspots on top of epithelial layers. Aggregating yeast cells 
might cause strong inflammation by influencing the immune response from intact cells in localized 
areas. Due to presumably high fungal pressure, low amounts of IL-1α might be released early by cell 
lysis and could impact as damage-associated molecular patterns (DAMPs) on neighboring cells, bind 





202. Dongari-Bagtzoglou and coworkers (2003) demonstrated that C. albicans wild type induced 50% 
less IL-8 of oral epithelial cells when IL-1R1 was neutralized with the IL-1 receptor antagonist (IL-1Ra) 
153. The present study could verify a damage-independent reduction of IL-8, but also IL-1α and IL-1β 
secretion by oral cells when blocked with the IL-1 receptor antagonist anakinra. However, a tenfold 
higher concentration of anakinra used in this study did not abolish the inflammatory cytokine release, 
indicating that secreted IL-6/IL-8 is only partly dependent on IL-1α signaling via IL-1R1 in oral cells. IL-
1-dependent induction of inflammatory cytokines seems to differ between epithelial cells, because 
Kim and coworkers (2013) could abolish IL-1 induced IL-6 secretion of lung epithelium with anakinra 
in a concentration-depend manner under non-damaging conditions 203. Notably, the MNN9 and 
MNN2 sextuple mutant induced a stronger IL-1 release. However, IL-1R1 blocking with anakinra 
dampened IL-1, but also IL-8 secretion to the same extent relative to the other strains. This suggests 
that the increased IL-1 level induced by these mutants might not be the cause of the observed 
increase in IL-6 and IL-8 secretion. Expression of IL-1 mRNA has been shown to occur as early as 1 h 
after C. albicans infection of keratinocytes and therefore Egusa and coworkers (2006) proposed an 
IL-1 signaling receptor 204. This receptor might recognize MNN9 and MNN2 sextuple mutant yeast 
cells stronger than wild type yeast cells due to aggregation or changes in the glycosylation status. 
7.3 Contribution of epithelial PRRs to the immune response 
Myeloid PRRs can recognize C. albicans cell wall components, such as N-linked mannan (by dectin-2 
and mannose receptor, MR), O-linked mannan (by TLR4), or β-glucan (by TLR2, TLR6, and dectin-1) 
101. Among the repertoire of TLRs, CLRs, NLRs, and RLRs, TLR2 and dectin-1 are by far the best studied 
PRRs in sensing C. albicans 167. The process of the receptor-mediated recognition of C. albicans on 
epithelial cells is still unknown 37. However, epithelial cells also express these PRRs, depending on the 
species, the cellular location in the host, and can differ between primary cells and cell lines. The 
majority of TLRs are constitutively expressed in the reconstituted human oral epithelium (RHE) 113. 
Similarly, human hepatic epithelial cells (HepaRG) also express TLRs (analyzed by flow cytometry 205 
and this study). In contrast to this work, one study showed that human renal epithelial cells only 
express TLR3 and TLR5 but not TLR2 and TLR4 (analyzed by transcriptional profiling of A498 206). Some 
PRRs are known to be expressed intracellularly, e.g. the microbial DNA sensing TLR9 112. However, 
PRRs expressed on cell surfaces can also be expressed intracellularly, which was observed for TLR4 in 
the lung epithelial cell line A549 207.  
To date, there is limited data on CLR expression and contrary results for dectin-1 have been published 
showing a crucial role in the C. albicans defense 167 or not 208. One group observed that dectin-1-
knockout mice were more susceptible to C. albicans systemic infection than wild type mice 167. 
However, a sublethal dose of 104 CFU did not kill wild type mice, while infection with a lethal dose of 
105 CFU reduced survival. The other group used a twofold lethal dose and did not see differences in 
survival of wild type or dectin-1-knockout mice 208. They  concluded that β-glucan on live fungal cells 
are masked by mannosyl residues and are therefore not accessible for dectin-1. However, the 
immune response also seems to be dependent on the initial fungal dosage. The contribution of 





expressed in oral RHE 126 and monolayer (this study), renal epithelial cells A489 (209 and this study), 
and airway epithelial cells A549 210, it is not an essential PRR to clear epithelial infections 30,211. 
Nevertheless, since stimulation of dectin-1 of hepatic cells induced a strong IL-8 release, dectin-1 
particularly seems to has an impact on the epithelial immune response and probably during 
recognition of C. albicans. For dectin-2 there is only one study showing no expression in oral RHE 126.  
In this study, a low basal expression was examined for TLR2, TLR4, dectin-1, and dectin-3 in hepatic, 
renal, and oral epithelial cells, with a stronger expression rate for all PRRs in hepatic cells. These data 
was observed from total cell staining that also included intracellularly expressed PRRs. 
Permeabilization of epithelial cells also circumvented high autofluorescence that was observed in test 
staining. Given that mucosal and parenchymal epithelial cells showed a similar expression of TLRs and 
CLRs, this could imply similar recognition and activation of an epithelial cytokine induction in response 
to C. albicans. However, the cell-specific cytokine release observed from oral, hepatic, and renal 
epithelial cells could conclude that early recognition of C. albicans might change PRR expression prior 
to or during infection to enable a stronger amplification of signal intensities. This study did not 
observe any change in PRR expression after co-stimulation with both IL-1β and TNF-α for 24 h or 
infection with C. albicans for 7 h. Other studies observed no increase in the transcriptional response 
of TLRs or dectin-1 during C. albicans infection of oral RHE or oral monolayer cells 113,119. This is in 
contrast to the work of Wagener and coworkers (2012) where they observed increased mRNA levels 
of TLR4 after 24 h of incubation of isolated C. albicans cell walls with oral epithelial cells 114. A 
knockdown of TLR4, however, did not change the cytokine profile during incubation with isolated cell 
walls. In addition, Bahri and coworkers (2010) described increased transcriptional expression of TLR2, 
TLR4, and TLR6 in a time-dependent manner in response to C. parapsilosis infection of gingival 
epithelial cells 212. Although the mRNA expression of TLR2 was also induced in an engineered human 
oral mucosa model, the transcript for TLR4 was downregulated in response to C. albicans after 24 h 
164. However, the comparability of PRR expression in the above mentioned studies is limited due to 
various experimental setups. For example, the latter used to cultivate C. albicans at 37°C that could 
already induce yeast-to-hypha transition and might change PAMP exposures. Nonetheless, previous 
findings indicate that the expression of PRRs might change at later time points in oral cells and suggest 
a quantification of PRR expression at later time points than 7 h. But, due to fast and invasive growth 
of C. albicans on and in the epithelial cell layer, quantification of PRR expression by flow cytometry 
or quantitative western blotting is technically limited. 
No single receptor can solely activate the immune response 213 and changes in the PRR expression 
was not observed. However, expressed epithelial PRRs might cluster homo- or heterologous into 
patches to synergistic enhance signal intensities 214. The collaboration of dectin-1 with TLR2 or TLR4; 
or dectin-1 with dectin-2; or dectin-2 with dectin-3 was shown in myeloid cells 215,216. However, in 
epithelial cells the knowledge about PRR collaboration is limited. The relevance of a specific PRR in C. 
albicans recognition can only be investigated by directly targeting it than analyzing downstream 
adaptor proteins that are shared within groups of PRRs (such as MyD88 for TLRs and Syk for CLRs 101). 





demonstrated not to inhibit c-Fos or MKP1 activation that is needed to induce an epithelial cytokine 
response 30. Similarly, blocked TLRs in particular or in combination (e.g. TLR2 and TLR4), or CLRs (and 
in combination with TLRs), the cytokine response of oral, hepatic, and renal cells was not affected 
(data not shown). This suggests that a heterologous PRR clustering is not involved in the PRR-
mediated cytokine response induced by C. albicans and further on raises the question how the 
receptor-mediated recognition of C. albicans results in an epithelial immune response 37. 
Although PRR expression remained unaltered and PRR clustering was not observed in monolayer cell 
cultures, during the interaction of epithelial cells, immune cells, and the pathogen, epithelial PRRs 
could mediate an innate immune response. Weindl and coworkers (2007) demonstrated a 
polymorphonuclear leukocyte (PMN)-dependent upregulation of O-mannan recognizing TLR4 in oral 
RHE resulting in antifungal defense 113. Interestingly, TLR2 that recognizes β-glucan was not involved 
in this immune response. These results indicate that cell wall O-linked mannan might be an important 
fungal PAMP in the recognition by TLR4 and subsequent epithelial activation. While a relatively strong 
expression of TLR4 was observed in uninfected oral, renal, and hepatic epithelial cells (this study), 
infection did not modulate mRNA expression of TLRs in oral RHE after 12 h or 24 h 113 that could also 
explain why infection did not upregulate TLR expression. 
To facilitate dissemination, C. albicans must cross endothelial cells lining blood vessels that are also 
an integral component of the innate immune system. As previously shown for epithelial cells, 
endothelial cells might also discriminate Candida morphology and express various inflammatory 
cytokines 217. Even though some studies revealed new signaling pathways that govern the host 
response in endothelial cells or epithelial cells 218,219, an influence or possible dependency of both cell 
types in the C. albicans immune response is not known. 
7.4 Activation of signaling cascades that induce cytokines is epithelial-
specific 
Oral epithelial cells can discriminate between commensal and pathogenic C. albicans via a biphasic 
MAPK response 30. Activation of a second-phase MAPK including MKP1 and c-Fos is a crucial event in 
the hypha-associated cytokine response by oral 30,220 and vaginal 31 mucosa. This activation, however, 
seems to be dependent on the multiplicity of infection (MOI), which was tenfold higher for vaginal 
than for oral cells 30,31. The present study analyzed signaling induction by applying a fungal load that 
reflects the high MOI of 10 to enable a comparison of the results between all tested cell lines. MKP1 
is expressed in the cytoplasm and its primary localization is in the nucleus. Because the subcellular 
localization of some MKP’s have been demonstrated in the nucleus and cytoplasm 221, whole cell 
lysates including nuclear proteins were examined. Interestingly, while all cell lines secreted IL-8 in 
response to fungal infection after 24 h, hepatic cells seem to induce this cytokine response 
independently from MKP1 phosphorylation. Moreover, using higher protein amounts or an even 10 
times higher MOI did not increase p-MKP1/MKP1 signal intensities or phosphorylation status in 
hepatic cells (data not shown). This implies that a C. albicans-induced cytokine response depends on 





Activation of oral MKP1 in response to C. albicans infection was confirmed in this study. Due to the 
fact that the MNN9 mutant induced stronger inflammatory cytokines, this strain could induce an 
stronger PRR activation that leads to more robust MKP1 phosphorylation resulting in an elevated oral 
IL-6 and IL-8 release. However, activation of MKP1 did not occur at early time points (within 6 h), 
since the MNN9 mutant induced a delayed but constantly increasing MKP1 phosphorylation. 
Activated MKP1 is stabilized by ERK1/2, and stronger ERK1/2 phosphorylation was observed with the 
MNN9 mutant, suggesting a progressive activation of MKP1 at later time points. In turn, C. albicans 
wild type induced highest ERK1/2 phosphorylation level at 4 h that declined afterward, consistent 
with MKP1 phosphorylation albeit to a lesser extent. Besides consistent MKP1 phosphorylation, the 
additional JNK activation that was also induced by the MNN9 mutant might contribute to the 
increased cytokine release. 
Activation of c-Fos could already be induced by mock infection in hepatic and renal cells, and the 
signal intensity did not increase after infection with C. albicans. Oral cells did not at all respond in c-
Fos activation towards infection. In contrast, Murciano and coworkers (2011) 98, Moyes and 
coworkers (2010) 30 and (2011) 31 showed c-Fos induction of infected oral cells. As a negative control, 
these groups used resting cells that were probably not treated with media exchange after seeding. 
Such a control is called untreated cells in the present study and did not induce c-Fos in renal and 
hepatic cells. To further circumvent the activation of MAPK signaling induced by the medium itself, 
these groups starved the cells prior to infection (oral communication, Marc Swidergall, 2019). The 
supernatant from mock-infected cells was exchanged prior to infection that already induced c-Fos 
signal in renal and hepatic cells. This media replacement without supplements was also performed 
for infected samples 16 h prior to infection following published protocols 98. It, therefore, appears 
that c-Fos induction occurs in reaction to stress and not to C. albicans itself. Interestingly, a 
hyperfilamentous NRG1 mutant with poor adherence capability on vaginal cells displayed only weak 
activation of c-Fos but was able to induce wild type similar IL-6 levels 31. The authors suggest further 
downstream targets of signaling required for cytokine production in different epithelial cells 
independent from the MAPK-induced c-Fos activation. In addition, they hypothesized that MKP1 and 
c-Fos might not be directly linked, because their activation is mediated via ERK1/2 and p38, 
respectively. Consistent with this hypothesis, stronger activation of ERK1/2 in oral cells by the MNN9 
mutant might elevate the activation of MKP1 independent from c-Fos. Vice versa, in hepatic cells c-
Fos could have a dominant role in the activation of the MAPK signaling resulting in IL-8 and other 
secreted cytokines in response to the C. albicans wild type. On the other hand, early but weak 
activation of MKP1 that did not increase during infection could explain the low amounts of secreted 
IL-6. 
NF-κB activation was directly analyzed by the phosphorylation of p65 of the p65/p50 NF-κB complex. 
Canonical activation of the p65/p50 NF-κB complex leads to the ubiquitination and proteasomal 
degradation of the suppressor IκBα. Free and activated NF-κB enables induction of gene expression 
that is required for the production of cytokines. The activation of NF-κB is independent of C. albicans 





PAMPs, and different stresses 222. Increased NF-κB activation contributes to inflammation and tissue 
damage, but in epithelial cells, it also acts on physiological immune homeostasis 223. It is, therefore, 
possible that one of these triggers led to the observed activation of phosphorylated p65 in all cell 
lines when mock or C. albicans infected. Moyes and coworkers (2010) observed a reduction of 
secreted cytokines when they blocked the NF-κB pathway during infection of oral epithelial cells 151. 
However, they also concluded that NF-κB is only partially involved in the cytokine response. The NF-
κB activation alone did not induce any cytokine secretion by oral, hepatic, or renal epithelial cells and 
might only moderately contribute to cytokine induction in combination with activated MAPK signaling 
pathways. 
7.5 Influence of the glycosylation status on the epithelial immune response 
The influence of the cell wall glycosylation status on the activation of MKP1 and c-Fos, and 
consequently the epithelial cytokine response, has been demonstrated for a variety of mutant strains 
with defects in N-mannan biosynthesis genes 98. Even though the recently discovered Candidalysin is 
the crucial fungal factor for cell lysis and activation of the oral and vaginal epithelial immune response 
17,56, cell wall glycosylation 98 and further features 56 might be required to fully activate epithelial cells. 
7.5.1 Deletion of MNN9 uncouples the correlation in damage and cytokine release 
Immune activation of epithelial cells that results in cytokine induction is dependent on hyphal burden. 
This study could show that a mutation in MNN9 induced stronger cytokine release by hepatic and 
oral epithelial cells without having an impact on host cell damage. Previous studies demonstrated 
that the MNN9 mutant is able to filament, but either develops true hyphae or pseudohyphae 97,98. 
Filaments of the MNN9 mutant stained for exposed chitin displayed no regular pattern for septa 
compared to the wild type or other mannosylation mutants analyzed in this study. However, when 
mnn9Δ/Δ was stained for total chitin with calcofluor white, regular septation was observed. Based on 
the characteristics that distinguish hyphal from pseudohyphal cells 224, the MNN9 mutant displayed 
no clear phenotype. On the one hand, the mutant did not display consistent parallel-sided walls and 
showed constrictions at mother-bud neck and many subsequent septal junctions that are 
characteristics of pseudohyphae. On the other hand, a characteristic for true hyphae was the first 
septum that appeared within the germ tube instead of the bud. It is possible that these characteristics 
of hyphal and pseudohyphal morphologies of the MNN9 mutant might be a result of the defect in 
mannosylation leading to the upregulation of β-glucan and chitin synthesis. 
Any defect in the glycosylation status, e.g. by the deletion in PMT1, MNT1/2, PMR1, or OCH1, 
affecting hyphal growth and resulting in no or weak activation of p-MKP1 and c-Fos signaling, has 
been shown to induce fewer cytokines from oral epithelial cells 98. Even though mnn9Δ/Δ displayed 
an altered filamentation as described before, the mutant was capable of activating required signaling 
of MKP1 and c-Fos 98, which resulted in yet stronger inflammatory cytokine response. This suggests 
that the glycosylation status indeed is important and exposure of PAMPs influences recognition and 





7.5.2 Exposure of PAMPs has no exclusive role in the activation of an epithelial 
response 
While previous studies usually analyzed the total cell wall composition, the present study focused on 
PAMP exposure and elucidated differences depending on the glycosylation status. Mannan covers 
the outer cell wall layer and masks β-1,3-glucan from recognition by dectin-1 in macrophages 167. 
Individual gene deletions from the MNN2 gene family reduce stepwise the α-1,2-mannose side-chain 
complexity while glucan exposure is increased 75,225. The glycosylation structure of the MNN9 mutant 
displays an even stronger impairment with a shorter α-1,6-mannose backbone and the absence of α-
1,2-mannose side-chains 60, which theoretically should facilitate stronger glucan exposure. However, 
all tested mannosylation mutants exhibited a similar increase in β-glucan exposure on yeast cells, and 
showed similar patterns on filaments.  
Dynamic unmasking of cell wall components is considered to be important during infection 85. Initially 
masked β-glucan by mannan becomes subsequently exposed during infection or treatment with 
caspofungin that allows fungal recognition 85. In the present study, unmasking was already observed 
in monocultures, suggesting that this a host-independent process. However, C. albicans 
mannosylation mutants exposed β-glucan along all filaments, whereas wild type filaments were 
exposed only on hyphal tips, secondary and branching hyphae. This exposure on newly built wild type 
filaments suggests a delay in the process of β-glucan masking by the mannan layer which was even 
more impaired in the mannosylation mutant. 
7.5.3 Fungal chitin might have an influence on the epithelial immune response 
Chitin lines the inner skeletal layer of fungal cell walls and is only exposed at bud scars 84. While the 
C. albicans yeast cell wall consists of about 2% chitin 87, hyphae contain five times more chitin 88. 
Upregulation of chitin synthesis occurs in response to stresses for compensatory regulation 14 and 
can appear as side effect in C. albicans mutants. Increased chitin exposure was observed for all 
mannosylation mutants by flow cytometry and immunofluorescence microscopy. However, stronger 
chitin exposure was not just the effect of a thinner mannan cell layer or the loss of cell wall integrity 
but most likely a compensatory upregulation of chitin synthesis in these glycosylation mutants. This 
could be proven by a heat inactivated wild type strain that exposed very low chitin levels compared 
to these mutants.  
Unmasking chitin has been shown by chemical perturbation or heat damage 84, and during neutrophil 
attack 92. Yeast cells treated with sublethal concentrations of caspofungin induces higher chitin 
exposure and has been shown to reduce the PRR-mediated cytokine response of PBMCs 226. Elevated 
chitin levels, however, protect C. albicans from antifungal treatment with caspofungin 227. Marakalala 
and coworkers (2013) could also show that elevated chitin levels in β-glucan exposing cells reduced 
the dependency on dectin-1-mediated controlling of fungal infections in vivo 228. Furthermore, chitin 
induces cytokines in a chitin particle size-dependent manner in murine macrophages 94 and human 
PBMCs. In epithelial cells, chitin exposure per se was not sufficient to induce an cytokine response. 
The non-filamenting OCH1 mutant exposed the highest chitin levels compared to their parental strain 





chitin could also be self-triggered by the host, as mammalian chitinase and chitotriosidase lead to 
chitin degradation into smaller particles that are known to mediate allergic immune responses 89. 
Even though so far no chitin-specific receptor is known 93, recognition of chitin involves the activity 
of NOD2, TLR9, and MR in oral cells 95.  
7.5.4 Glycosylation mutant strains mimic the cell wall of clinically relevant 
isolates 
To analyze the influence of cell wall glycosylation on the host immune response, gene deletions 
involved in mannosylation processes have been used regularly. Interestingly, some of these artificial 
strains mimic the cell wall from isolates adapted to specific environmental conditions 229. 
Phosphomannan is considered for efficient phagocytosis 80 and a defect in the attachment of 
phosphomannan by MNN4 mimics the cell wall of strains growing in acidic conditions, e.g. in the 
female reproductive tract 79,229. Furthermore, mutations in the MNN1 or MNN2 gene family that alters 
the mannan chain length and complexity could mimic C. albicans strains growing in blood and serum 
230. Mannosylation deletion strains are still flexible in PAMP exposure, as it was demonstrated for the 
MNN2 sextuple mutant usually exposing high amounts of β-glucan in high glucose medium, while 
incubation in lactate containing medium restores this phenotype 231. A strain that exhibits the cell 
wall of a MNN9 mutant might not exist under specific conditions, because this defect would occur 
early in the mannosylation and displays only a rudimentary N-mannan backbone.  
Deletion of genes involved in glycosylation can have an impact on the whole cell wall structure, which 
is not just the removal of a specific epitope 229. This includes an altered cell wall proteomic structure, 
which is known for biosynthesis genes with fundamental roles in mannosylation steps, e.g. OCH1 68. 
One of the well-known cell wall-associated protein families are secreted aspartyl proteinases (Saps) 
that appear to mediate the epithelial cytokine induction 21,204 and an increased expression might 
explain the elevated cytokine response induced by the MNN9 and MNN2 sextuple mutant. Of the ten 
known C. albicans Saps, Sap9 and Sap10 are incorporated into the cell wall via a 
glycosylphosphatidylinositol (GPI)-anchor 51. It can be assumed that Sap9 expression is not reduced 
in the MNN9 and MNN2 sextuple mutant, since the absence of this protease has been demonstrated 
to increase adhesion to oral cells and attenuates oral cell damage 54. While data on Sap secretion or 
incorporation is limited for glycosylation mutant strains, the extracellular matrix proteome of a MNN9 
mutant displayed only minor changes 100. Bates and coworkers (2013) hypothesized a differed protein 
surface charge rather than a modified glycosylation status itself for the avirulent MNN14 mutant 78. 
This strain, belonging to the MNN1 gene family, displays only minor structural defects in the α-1,2-
mannose side-chains and no impairments in the α-1,6-mannose backbone. Interestingly, the 
outcome of altered mannan biosynthesis between Candida species can result in contrary virulence, 
with the most prominent examples of deletion in ANP1 or MNN2 resulting in hypervirulence of C. 
glabrata 232 and hypovirulence of C. albicans 60. However, the specific role of cell wall proteins on 
filamentation, host recognition, and induced immune response needs to be elucidated in more detail. 
In addition, moonlighting proteins could perform different so far unknown functions, which are not 





7.5.5 Impaired adhesion does not necessarily alter the epithelial immune 
response 
Adhesion to host cells is a prerequisite for C. albicans to colonize mucosal surfaces and therefore the 
pathogen expresses various adhesins, e.g. Als3p, Hwp1p, and Eap1p 40. A defect in adhesion is also 
associated with fragile biofilm formation as it was observed for deletion in MNN9, OCH1, and to a 
lesser extent in PMR1 78,100. Reduced adhesion capability can decrease the epithelial activation 31, 
however, it does not necessarily cause a reduced cytokine response 98. While a defect in MNN9 or 
MNN2 decreased adherence to hepatic cells, these strains induced an elevated cytokine response in 
hepatic cells. A stronger cytokine response was also observed in oral cells, but adherence to this cell 
line, as determined in this study, was not impaired in the MNN9 and MNN2 sextuple mutant. This is 
in contrast to observations from Murciano and coworkers (2011) showing reduced adhesion of a 
MNN9 mutant to oral epithelial cells determined by CFU counting 98. A likely explanation for these 
opposing results could be that glycosylation mutants are known to aggregate 60,68,81,97,177. In this study, 
aggregating cells of glycosylation deficient strains were separated with a syringe by physical force, 
resulting in partially separated cells without impairment in fungal cell viability. A full separation could 
be achieved by ultrasonic application, but it also decreased viability drastically (unpublished data). 
7.5.6 Candidalysin, the “missing link” in morphogenesis and cell damage? 
Recently it has been shown that Candidalysin (Ece1), a secreted fungal peptide toxin, is fundamental 
in damaging epithelial membranes and activating the epithelial immune response 17. The authors 
demonstrated that a defect in ECE1 did not impair filamentation, but abolished epithelial damage 
and cytokine release. Interestingly, the MNN9 mutant expresses and secrets more Candidalysin (the 
functional peptide Ece1-III; analyzed by LC-MS/MS; communicated by Selene Mogavero, HKI Jena). 
Increasing Candidalysin concentrations elevated the IL-1 release from myeloid cells 140, which might 
also explain the stronger activation of oral IL-1 release induced by the MNN9 mutant. An putatively 
increased secretion of Candidalysin by the MNN9 mutant, however, did not alter the damage 
potential of oral epithelial cells. The in this study observed stronger activation of components from 
the MAPK signaling pathway strengthens the hypothesis of a partly damage-independent cytokine 
induction by so far unknown factors. Another study supports this theory, where Ece1 expression did 
not correlate with the degree of LDH release 234. Moyes and coworkers (2016) suggest that Ece1-III 
might not solely be secreted into invasion pockets but could also activate surrounding cells without 
any contact to hyphae 17. It, therefore, appears possible that Candidalysin is not only per se the 
inducer of epithelial cell damage, but also a main activator of signaling cascades resulting in an 
epithelial cytokine response. 
7.6 Early recognition of the β-glucan unmasked MNN9 mutant could induce 
neutrophil recruitment in the kidney that reduces virulence in murine 
disseminated candidiasis 
The commonly used murine model of disseminated candidiasis resulted in an organ-specific outcome: 
while spleen and liver controlled C. albicans infection by secreting neutrophils, the kidney showed a 





and other cytokines appeared as early as 12 h after infection and further increased within 48 h. Kidney 
fungal burden consistently increased and as the infection progressed, cytokine-driven accumulation 
of immune cells ultimately contributed to renal pathology 145. Moreover, C. albicans morphologies 
also differed between these organs, because hyphae have been not observed in spleen and liver.  
A defect in the mannosylation status of C. albicans has been demonstrated to generally confer less 
virulence in murine disseminated candidiasis, regardless how strong the structural impairment was, 
e.g. by deletion of OCH1 68,107, PMR1 81, MNN10 72, or the MNN2 sextuple mutant 75. Likewise, this 
study demonstrates that the deletion of MNN9 resulted in complete survival of mice for 21 days. A 
minor gene-dosage effect was observed for mice infected with the revertant +MNN9 strain containing 
one functional MNN9 allele, resulting in 2.5 days longer median survival compared to the wild type. 
The fact that the kidney is the target organ in disseminated candidiasis could be confirmed by the 
highest fungal burden in this organ. Surprisingly, the MNN9 mutant also displayed a high kidney 
burden after 21 days that implicates an impaired host immune response. However, kidney burden 
induced by the MNN9 mutant was reduced compared to that induced by the wild type between day 
three and five after infection. This could implicate that the host prevented massive colonization of 
the MNN9 mutant or could even partially clear infection. However, limitations are the different time 
points of fungal burden analysis and lacking data at early time points of infection with the MNN9 
mutant.  
50% of mice infected with the MNN9 mutant displayed one healthy and one enlarged and pale kidney 
filled with granuloma structures that were not filled with immune cells but rather bulged with fungal 
filaments. Granuloma formation is expected during chronic infection and suggests a protective 
mechanism to prevent further fungal proliferation. This unilateral infection of either left or right 
kidney has been observed for low infectious doses 235. The infectious dose of 5x105 cells per mice was 
obtained by single cell counting and verified by CFU plating. However, as a result of the strong 
aggregating phenotype of the MNN9 mutant the cell number observed by CFU plating was lower than 
the single cell counting. Therefore, cell aggregation might have reduced the effective infectious dose 
calculated by CFU plating that resulted in unilateral kidney infection. On the other hand, CFU plating 
from organ samples most likely underestimated the number of fungal burden caused by the MNN9 
mutant. A possible solution to calculate total cell numbers for comparison between wild type and 
mutant strains could have been quantitative PCR to determine the amount of fungal rDNA. It is not 
completely understood how the fungus systemically translocates into organs, and significantly less is 
known about translocation of aggregating cells. It might be possible that accumulation of few yeast 
cells could enter endothelial and epithelial cells, whereas bigger aggregates that are unable to cross 
these barriers remain in the bloodstream and are cleared subsequently. 
Interestingly, kidney fungal burden was also seen by other groups when systemically infected with 
avirulent or less virulent mannosylation mutant strains: an avirulent PMR1 mutant 81 with a decreased 
ability to form normal filaments in vitro, or the MNN2 sextuple mutant 75 forming normal hyphae in 
vitro. Both strains induced high fungal burden in the kidney after 28 days of infection. Surprisingly, 





formation was not avirulent, but displayed a reduced virulence after 28 days 68,107. Moreover, wild 
type-like kidney fungal burden was also observed for the OCH1 mutant and the authors suggest that 
this is due to an altered host-fungal interaction driven by the impaired invasive growth by this mutant 
68. 
Mnn9 and Mnn10 are both part of the mannan polymerase II complex and might share structural 
similarity, however, the N-glycan structure for the MNN10 mutant has so far not been determined. 
As well as the MNN9 mutant, the MNN10 mutant is reduced in virulence in murine disseminated 
candidiasis 72. The authors observed a reduced kidney fungal burden caused by the MNN10 mutant 
two and five days after infection, accompanied by increased cytokine levels and early recruited 
neutrophils and monocytes in the kidney. Consequently, early recruited neutrophils could partially 
clear the MNN10 mutant infection, and with decreasing fungal burden, neutrophils and monocytes 
were also less abundant in the kidney. Since Mnn9 and Mnn10 are both mannosyltransferases 
involved in the same step of N-mannosylation, the MNN9 mutant might also induce a similar and 
early neutrophil recruitment that reduces fungal burden.  
In conclusion, C. albicans cell wall mannosylation might contribute to the modulation of the kidney 
immune response, whereas unmasking of the cell wall leads to early immune cell recruitment that 
could result from an elevated epithelial cytokine induction. 
7.7 Concluding remarks and outlook  
The activation of mucosal epithelial cells is considered to be dependent on C. albicans-induced 
damage. This study demonstrates that epithelial cells from the hepatic and renal parenchyma also 
require C. albicans damage to induce cytokine secretion. Different quantities and qualities of secreted 
epithelial cytokines suggested site-specific PRR expression and signaling. While PRR expression did 
not differ between epithelial cells, activation of MKP1 revealed epithelial-specific outcomes that was 
not dependent on early-induced cell damage. This demonstrates that the epithelial immune response 
is site-specific and suggests that further signaling components might be involved to induce cytokine 
releases. 
This study further demonstrates that epithelial cells from different sites differently release 
inflammatory cytokines in response to different glycosylation mutant strains. While the MNN9 
mutant induced a stronger cytokine release by hepatic and oral epithelial cells, renal cells were less 
activated compared to the parental strain. One remaining question is the impact of epithelial cells on 
the total host immunity in response to disseminated candidiasis. 
Taken together, the results obtained in this thesis demonstrate that commonly known fungal factors 
leading to adhesion, hyphal growth and maintenance, invasion, Candidalysin secretion and host cell 
damage, expression of hyphal-associated genes, activation of the epithelial MAPK/c-Fos and MKP1, 
and masking of immunostimulatory cell wall moieties collaborate in a complex network to confer C. 










Fig. S1. C. albicans mutant strains selected for a putative modulation of the epithelial cytokine response. 
Confluent intestinal, hepatic, renal, and oral epithelial cell lines were infected with 11 different C. albicans 
transposon mutants for 24 h under standard culture conditions. Cell culture supernatant was assessed for 
lactate dehydrogenase (LDH, A) measuring epithelial cell damage, or the amount of IL-8 by ELISA (B). Data 
represent mean values +/- SD from three independent experiments. Dotted baseline: 100% LDH (A) or IL-








Fig. S2. Subtle defects in N-mannosylation by MNN14 and MNN22 did not affect epithelial cell damage 
and cytokine secretion. 
Confluent renal (A) and oral (B) epithelial cell lines were infected with MNN14 or MNN22 mutants for 24 
h under standard culture conditions. Cell culture supernatant was assessed for lactate dehydrogenase 
(LDH) measuring epithelial cell damage, or the amount of IL-6 and IL-8 by ELISA. Data represent mean 








Fig. S3. Epithelial cells influence hyphal growth of the C. albicans MNN2 sextuple mutant. 
Hyphal length of different C. albicans strains was measured after incubation on glass (A) or hepatic, renal, 
and oral cells (B) for 4 h. The hyphal growth was impaired of mnn9Δ/Δ on epithelial cells and glass, while 
hyphal growth of the MNN2 sextuple mutant was not impaired on glass cover slides without host cells. 
Data represent mean values +/- SD from two (A) or at least three independent experiments when 







Fig. S4. Exposure of cell wall mannan, β-1,3-glucan, and chitin on C. albicans glycosylation mutant 
strains. 
Representative histograms of at least three independent experiments of C. albicans SC5314 and mnn9Δ/Δ 







Fig. S5. Chitin staining of the filamentous mnn9Δ/Δ reveals normal separated cells. 
C. albicans mnn9∆/∆ was co-incubated with oral epithelial cells for 4 h and stained for total chitin (blue) 
and exposed chitin (green). Total chitin staining was performed once when incubated with oral cells and 






Fig. S6. Fungal burden in spleen, liver, and brain after C. albicans systemic infection in mice. 
BALB/c mice were infected intravenously with 5x105 C. albicans strains and survival was assessed for 21 
days. Depicted is one representative from two independent experiments with 8 mice per group. Fungal 







Fig. S7. Analysis of c-Fos activation after 4 h of infection with C. albicans. 
c-Fos expression in untreated, mock-infected, and with C. albicans SC5314 infected epithelial cells after 4 







Fig. S8. Clinical score of mice after C. albicans systemic infection. 
BALB/c mice were infected intravenously with 5x105 C. albicans strains of wild type, mnn9Δ/Δ or the 
revertant strain +MNN9 and survival was assessed for 21 days. To monitor mice health status, weight, 
temperature, behavior and fur were assessed at least on a daily basis. Changes of weight and temperature 
were allocated to a specific clinical score, while behavior and fur were directly scored. Mice were 
euthanized when the clinical score summary reached 5 or more points, or when temperature or weight 
dropped massively. 
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